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ABSTRACT
The rapid development of biomaterials and biotechnology has advanced corneal
bioengineering during the past decade. Collagen, the main component of human cornea
which is responsible for maintaining its transparency and mechanical properties, has
attracted unparalleled attention and demonstrated promising prospective on the
preparation of bioengineered cornea, due to its outstanding biocompatibility both in vitro
and in vivo. The main difficulties for utilizing collagen for corneal bioengineering reside
in how to fabricate a structure that mimics natural cornea.
The main goal of this study is to design and prepare scaffolds that exhibit a structure that
mimics the native cornea while possessing the physiochemical and biological properties
required by qualified corneal substitutes. Collagen membranes were fabricated using an
electro-compaction method and applied either as substrates for corneal epithelial
bioengineering or as structural layers to rebuild a corneal stromal model.
For corneal epithelial bioengineering, the most common and effective strategy is using
substrates that are capable of supporting the growth and transplantation of corneal
epithelial cells and regenerated tissue. Here, electro-compacted collagen (ECC)
membrane was investigated and compared with conventional / non-electro-compacted
cross-linked collagen (NECC) membrane. In Chapter 3, scanning electron microscopy
(SEM) revealed that, unlike NECC in which collagen fibrils are arranged in a random
fashion, those obtained using electro-compaction were well-organized and aligned in one
direction. The mechanical properties, including storage modulus, tensile and compressive
modulus, were then studied and confirmed that the compaction process resulted in
enhanced mechanical performance. The light transmittance in visible light range and
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glucose permeability, two significant virtues for qualified corneal transplant, were
sequentially evaluated to assess the eligibility of ECC for epithelial application.
In Chapter 4, a human corneal epithelial cell line was seeded on ECC and NECC surfaces
to evaluate cell viability and proliferation using Live/Dead cells staining and a Prestoblue assay, respectively. Cell attachment of HCECs, an essential prerequisite for corneal
epithelial reconstruction, was then studied by washing cells-attached scaffolds using PBS
at different time points. The cells that remained firmly attached were quantified using a
Presto-blue assay and the cell spreading area was characterized using F-actin/DAPI
staining and analysed using ImageJ. While HCECs were able to proliferate at a similar
rate on ECC and NECC membrane with confluence both achieved at day 5, those on ECC
demonstrated considerably enhanced initial attachment with cell adhesion, achieved with
a larger spreading area and better elongation.
For corneal stromal bioengineering, the work described in Chapter 5 presented the first
example of a robust hCSCs (Primary human corneal stromal cells)–encapsulated
biomimetic corneal stromal model (CSM) consisting of orthogonally arranged collagen
fibrils without any synthetic materials. The hCSCs-seeded ECC membranes composed of
aligned collagen fibrils were assembled into a layer-by-layer structure with the fibrils of
each layer orthogonally arranged in a way similar to that of native human corneal stroma.
The surface and cross-sectional morphology of scaffolds were confirmed using scanning
electron microscopy (SEM), and F-actin/DAPI staining results indicated that the
orientation was directed by the aligned collagen fibrils. The degradability, transmittance
over the visible light range and glucose permeability of CSM were monitored over 2
weeks in culture medium.
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In a healthy human cornea, keratocytes residing in corneal stromal maintain stromal ECM
(extracellular matrix) and do not proliferate. Upon injuries to stroma, however, corneal
keratocytes can be activated, resulting in migration, proliferation, and differentiation into
corneal fibroblasts/myofibroblasts. In Chapter 6, Prestoblue assay and Live/dead cells
staining revealed that hCSCs were highly viable and quiescent in the CSM up to 2 weeks;
indicating a similar state in which corneal keratocytes of human corneal stroma exist. The
phenotype of hCSCs in CSM was investigated by immunostaining using human corneal
fibroblast marker (alpha-SMA). Moreover, the influence of 2D ECC membrane and 3D
CSM on the corneal keratocytes (ALDH3A1) and fibroblasts (alpha-SMA and thy-1)
markers of hCSCs was analysed by qPCR. Interestingly, while the existence of aligned
collagen fibrils (2D ECC and 3D CSM) were both able to significantly downregulate
alpha-SMA and thy-1 expression compared with TCP, hCSCs in 3D CSM showed
considerable upregulation of ALDH3A1 compared with those on 2D ECC membrane and
TCP.
In conclusion, 2D ECC membrane showed great promise for corneal epithelial
bioengineering, being a superior candidate compared with conventional collagen gel. The
3D biomimetic corneal stromal model described herein lays a foundation to build
advanced 3D corneal tissue in vitro, manipulating the keratocytes and fibroblasts markers
expression of hCSCs and validating clinical suitability.
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General Introduction
This chapter presents work that has appeared in the published
articles “Biomaterials for corneal bioengineering.” Chen Z, You J,
Liu X, Cooper S, Hodge C, Sutton G, Crook JM, Wallace GG.
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1.1 Cornea and corneal transplantation
Cornea is a transparent, avascular and highly innervated tissue located at the anterior part
of the eye. Its primary functions are to transmit and refract light entering the eye and to
protect the eye from mechanical damage, UV light, and infection. Corneal transplantation
is an important surgical treatment for injury and disease [1]. The World Health
Organization (WHO) 2010 global survey estimated 39 million people with blindness. 12%
or 4.9 million have bilateral corneal blindness [2]. From regional surveys, 23 million
people are estimated to suffer from unilateral corneal blindness globally [3]. The causes
of corneal blindness are diverse and include various corneal dystrophies, infectious and
inflammatory corneal disorders, and corneal surface damage.

Corneal transplantation remains an important treatment for corneal diseases/conditions
with 72% of recipients showing visual improvement [4]. However, several unfavourable
factors impede the utilization of corneal transplantation. In particular, although allogeneic
tissue from human donors remains the best option for corneal graft replacement, this
approach is hindered by the shortage of donor tissue and by transplant rejection [5].

A global survey on corneal transplantation showed there were a total of 184,576 corneal
transplantations conducted in 116 countries and 284,000 corneas procured in 2012 [6]. It
also reported a substantial lack of tissue with only 1 cornea available for every 70 patients
worldwide [6]. The incidence of immunologic corneal graft rejection has decreased
compared with solid organ transplantation by virtue of the cornea being avascular, an
immunosuppressive ocular microenvironment, and the phenomenon of anterior chamberassociated immune deviation. Nevertheless, a recent study during a 5-year follow-up
shows 23% subjects experienced at least one rejection event after Penetrating
3

Keratoplasty (PK) [7]. Normally, corneal immunologic rejection can be reversed with
topical steroids, but severe rejection can lead to fast and permanent loss of endothelial
cells and transplant failure. If no clinical improvement occurs the only option is to
surgically remove and replace the damaged cornea with a further corneal transplant [5,
8]. What is more, corneal rejection can result in permanent blindness [9]. Therefore,
allogeneic corneal transplantation has limitations and a bio-engineered cornea could
potentially address the key issues of tissue availability and tissue rejection.

The first full-thickness PK was performed on 7 December 1905 by Dr. Eduard Zirm [11].
The first case of lamellar keratoplasty (LK; removal of anterior layers of the cornea) was
successfully conducted prior to this but early outcomes were poor [11]. With the
development of microsurgical instruments, and improved surgical techniques in the past
10 years, selective lamellar keratoplasty (SLK; removal of diseased layers of corneas
only), as the successor to LK, has significantly improved keratoplasty [1]. Specifically,
SLK consists of anterior lamellar keratoplasty (ALK) and endothelial keratoplasty (EK).
ALK replaces epithelium and stroma while retaining uninfected healthy stroma and
endothelium. Alternatively, a deep anterior lamellar keratoplasty (DALK) is performed
if almost all the stroma has to be removed. DALK has been successfully used in treating
keratoconus patients [12]. In contrast, EK replaces only Descemet’s membrane and the
endothelium, and is mainly used for corneal disease caused by endothelial disorders or
failures. Compared with PK, ALK and DALK are less likely to cause loss of host
endothelial cells and thereby avoid endothelial rejection. EK can theoretically provide
better visual outcomes due to improved astigmatism [1]. Recently, the frequency of
lamellar procedures is steadily increasing [13]. Nonetheless, all the above-mentioned
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techniques use donor corneas and therefore graft tissue availability and rejection remain
challenging.

Since the discovery of limbal stem cells, autologous or allogenic limbal tissue
transplantation have been considered for reconstructing the injured ocular surface [14].
For patients with unilateral LSD, a limbal autograft from the healthy contralateral eye is
the best option for avoiding tissue rejection [15]. By contrast, the treatment for severe
bilateral ocular surface disease is largely dependent on procuring allogeneic tissue from
the limbal region of corneal tissue donors [14]. Benefits aside, it remains difficult to
estimate the appropriate amount of limbal tissue from a donor eye for autologous
transplantation. Inadequate volume may lead to failure of eye surface-reconstruction and
excess extraction tends to impair the healthy donor eye. Amniotic membrane (AM) has
commonly been used as a natural substrate for limbal epithelial cell culture and delivery,
but the potential for infection and shortage of source tissue necessitate better alternatives
[16]. Similarly, for reversible blindness caused by corneal endothelial cell failure, there
is an urgent need for cell-carriers to replace failed endothelium with ex-vivo expanded
endothelium cells [17].

Based on the significant shortfall of donor tissue for corneal transplantation, corneal
bioengineering for partial or entire reconstruction of cornea using a combination of
biomaterials, corneal cells and engineering methods, is rapidly advancing as a promising
solution to produce suitable substitutes [18]. The ultimate goal of corneal engineering is
to assemble functional cell-laden scaffolds that are able to restore, repair and replace
human cornea. Although a variety of materials have been studied towards fabricating
bioengineered cornea, nothing suitable has been identified to date, with the search
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continuing for new yet to be tested biomaterials and fabrication methods.

1.2 Human cornea anatomy and function
The human cornea is the first tissue through which light enters the eye and accounts for
two thirds of the refractive power of the eye, directing the light rays towards the pupil
[19]. Anatomically, the cornea is wider along the horizontal meridian compared to
vertically. Population studies indicate the average horizontal diameter of the cornea in
adults is around 11.80mm [20, 21], and the vertical diameter is around 10.63 mm [22].
The radius of corneal curvature is steepest at the centre and flattens towards the periphery,
with a mean central radius of curvature being approximately 7.7 ± 0.30mm [23]. Until
recently, cornea was understood to comprise five-layers, including anterior to posterior:
epithelium, Bowman’s layer, stroma, Descemet’s membrane and endothelium (Figure
1.1). In 2013, Dua et al. reported a sixth layer termed pre-Descemet’s layer that lies
between the stroma and Descemet’s membrane [24], although there is still controversy
around its existence. Among these layers, epithelium, stroma and endothelium are cellular
layers, whereas Bowman’s layer, pre-Descemet’s layer and Descemet’s membrane are
acellular layers (Figure 1.4).
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Figure 1.1. Cross-sectional schema of cornea.

The cornea is one of the most innervated tissues of the body, with the majority of nerves
being sensory and derived from the ophthalmic division of the trigeminal nerve (5th
cranial nerve) [25]. The nerve bundles enter the cornea through limbus where they form
the limbal plexus, then extend to the peripheral corneal stroma. The stromal nerve bundles
start to branch at the mid-peripheral area, passing through Bowman’s layer forming the
sub-basal nerve plexus that locates in the basal epithelial layers. Individual nerve fibres
arising from the sub-basal plexus move anteriorly and terminate in the superficial
epithelium as free nerve endings [25]. Corneal nerves are important for both protection
and maintaining the integrity of the ocular surface, and corneal sensation and nerve
density are important indicators for cornea recovery after surgery [25] [26].

1.2.1 Corneal epithelium
Corneal epithelium is the outermost layer of cornea and the major refractive element of
the eye. It is 40-50µm thick and consists of 4 to 6 layers of stratified and nonkeratinized
squamous epithelial cells [19] (Figure 1.2). The most superficial corneal epithelial cells
7

form 2~3 flat layers with glycocalyx-covered microvilli on the top surface. The
glycocalyx is indispensable for the stability of tear film, which in turn contributes to
normal vision. These surface cells form tight junctions that prevent tears, toxins and
microbes from entering the eye. Immediately below the superficial cells is the middle
wing cell layer, and the inner basal columnar layer. The basal cell layer is approximately
20 mm thick and the source of wing and superficial cells and, apart from limbal stem cells
and transient amplifying cells, are the only corneal cells capable of mitosis. [27]
Furthermore, the basal cells are firmly connected to each other by lateral gap junctions
and zonulae adherens and strongly attached to underlying basal lamina by
hemidesmosomes [27].

Figure 1.2. Cross-sectional schema of the corneal epithelium.
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Figure 1.3. Schema of the limbal stem cell niche.
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Figure 1.4. Light microscopic image of human cornea stained with hematoxylin and eosin.
A human cornea is uniformly thick across the central region with increased thickness
towards the limbus. B. A cross-sectional image showing the six-layered corneal structure.
10

C. Enlarged image of the limbus showing the presence of blood vessels (BV) and
undulating basal epithelium (asterisks).

Corneal epithelial cells regenerate every 7-10 days through centripetal migration starting
from the limbus, located on the corneal rim at the junction between sclera and cornea
(Figure 1.3) [28]. The limbus contains corneal epithelial stem cells that are important for
corneal epithelial homeostasis (Figure 1.4C). The stem cells divide asymmetrically to
produce transient amplifying cells, which migrate towards to the central cornea to become
basal central corneal epithelial cells. These cells then further differentiate and migrate
towards the corneal surface to become the wing and superficial corneal epithelial cells
(Figure 1.3) [29]. In the normal resting state, p63 is totally absent in corneal epithelium.
When wound healing occurs, the αisoform of ▽Np63(N-terminally truncated transcripts
generated by p63 gene) was reported to be significant to identify the stem cells residing
in the basal layer of limbus. ▽Np63α, as an indicator for the regenerative proliferation
of corneal epithelium, can be also detected in the central cornea due to the migration of
LSC once activated [30] The main function of the corneal epithelium is to form a barrier
to prevent toxins and microbes from entering the epithelium, integrate with tears to
provide a smooth layer for light refraction, and transfer water and soluble components
into or out of the stroma [31]. The most posterior layer of the epithelium is a basement
membrane (BM), where the basal epithelial cells attach. The BM is about 40-60 nm thick
and consists of type IV collagen, laminin, perlacan (a heparin sulfate proteoglycan), and
nidogen (a sulfated glycoprotein) [32]. Together, the basement membrane is essential for
the adhesion and polarity of epithelial cells, and to modulate cellular signaling and
trafficking between epithelium and stroma [32].
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1.2.2 Bowman’s layer
Between the epithelium and stroma layers lies the Bowman’s layer (Figure 1.1), which
has a smooth anterior surface abutting the epithelial basement membrane, with its
posterior side merging with stroma [33]. The Bowman’s layer is acellular and has
numerous pores allowing passage of nerve bundles [33]. It consists mainly of collagen
types I and III, as well as types V and VI [34-36], which form collagen fibrils with a
diameter of 20-25μm. The individual collagen fibrils interconnect to generate a sheet
about 8-12μm [37]. The thickness of the Bowman’s layer decreases with age [37] and it
does not regenerate following trauma or removal [33]. It is hypothesized that the
Bowman’s layer is formed early in the development of cornea via the interaction between
corneal epithelial cells and keratocytes in the stroma [38]. Its absence does not appear to
prevent re-epithelialization following surgery or trauma [38]. However, the bowman’s
layer has been reported to assist with stromal wound healing and restoration of the
subepithelial nerve plexus [33].

1.2.3 Stroma
Corneal stroma accounts for roughly 80-85% of the entire corneal thickness, and affords
many biochemical properties of cornea including tensile strength, stability and
transparency [32]. The collagen fibrils in stroma are bigger than in the Bowman’s layer
with diameters ranging from 25-35 nm [37]. Collagen type I is predominant in stroma.
Together with type III and V collagen they form collagen fibrils. Type VI collagen occurs
as fine filaments in the inter-fibrillary matrix of the stroma [36]. The collagen fibrils form
triple-helix bundles with diameters of 250-340 nm, which align to form a flat lamellar
sheet [37]. The lamella sheets are enveloped by proteoglycans decorated with keratin
sulfate or chondroitin sulfate, and preserve corneal hydration and transparency [39]. The
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stroma consists of 250~300 collagen lamellae with a width of 10-320μm and a thickness
of 0.2-2.5μm [40]. The arrangement of the lamellae in the stroma is heterogeneous, with
the collagen fibres being interwoven in the anterior stroma and parallel in the mid to
posterior stroma [40]. In addition, the intervals between lamellas are filled with
keratocytes, which occupy more than 20% of the stroma. These cells are responsible for
the stability of lamellar organisation and regulation of corneal stroma extracellular matrix
components via synthesis of collagen and proteoglycan [41]. The framework of corneal
stroma is important for the transparency and mechanical property of the cornea.

Once the normal integrity or the interconnection with the Bowman’s layer and
Descemet’s membrane is interrupted, the stromal wound-healing process is activated.
Due to the distinct avascular nature of the cornea, a critical difference between stromal
healing and that of other body tissues such as skin is the absence of vascular component
[42].

1.2.4 Pre-Descemet’s layer and Descemet’s membrane
The pre-Descemet’s layer is posterior to the stroma and anterior to the Descemet’s
membrane. The recent discovery of Pre-Descemet’s layer remains controversial with
many studies suggesting the layer to be part of the stroma [24, 43]. However, emerging
evidence of the structure, constitution and clinical importance support its existence as a
distinct layer. It is made up predominantly of type I collagen but includes type VI collagen,
which assembles into 5-8 thin lamellae with an overall thickness of 10-15 μm [24]. A
recent study suggests that it consists of high levels of elastic fibres that originate within
the posterior limbus in the trabecular meshwork [44]. This elastic fibre network in the
pre-Descemet’s layer could be important for anchoring the cornea as well as the trabecular
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meshwork to the limbus and peripheral cornea [44]. The clinical importance of the PreDescemet’s layer is supported by the big bubble technique being unsuccessful if the layer
is disrupted [45]. The predominant collagen in the Descemet’s membrane is type IV,
although it also includes collagen type VIII, XII, laminin, perlecan, nidogens, vitronection
and fibronectin [46]. In contrast to the Bowman’s layer, its thickness gradually increases
from birth to adulthood, expanding to between 5-10μm [47]. It is secreted by endothelial
cells to form the basement membrane for endothelial cells to anchor [47].

1.2.5 Endothelium
The human corneal endothelium is composed of a single layer of hexagonal shaped cells
with a thickness of around 5μm. Similarly, adjacent endothelial cells are characterized by
lateral gap and tight junctions and are vertically attached on the Descemet’s membrane
by numerous hemidesmosomes [48]. Once the endothelium layer is formed, the
endothelial cells become mitotically inactive. Human corneal endothelium initially
comprises approximately 4500cells/mm2, with the total endothelial cell number
decreasing with age, while the cell surface area increases.[49]. The main indicator for an
eye bank to select corneas after storage for penetrating keratoplasty is the endothelial cell
counts [50]. Generally, donor corneas considered for transplantation need to have an
endothelial cell density of ≥ 2000cells/mm2.

While acting as a barrier to restrain fluid into the cornea, the endothelial cells prevent
excessive hydration (78% water content) of the stroma, maintaining stromal
deturgescence by a passive pump-leak process that moves ions and water from hypotonic
stroma to hypertonic aqueous humor [51]. The whole process has been shown to be
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associated with Na+, K+– adenosine triphosphatase (ATPase) pumps that reside in the
basolateral membrane [52].

Thus, the endothelium is critical to maintaining the transparency and nutrition of the
cornea via this “pump-leak” mechanism. It is rich in ion and water channels for transfer
of nutrients from aqueous humor to cornea [53], and its function to nourish the cornea
and inability to regenerate renders it key to determining by assessment the suitability of
cornea for transplantation. Due to their mitotically inactive nature, once the number of
endothelial cells decreases, the surrounding cells gradually infiltrate the vacant region to
maintain tissue integrity. The deformation of endothelium, however, tends to impair the
pump function [54].

1.3 Biomaterials for corneal bioengineering
Biomaterials employed for engineering corneal substitutes must replicate the
structural and functional requirements of native cornea. Briefly, as scaffolds for cell
support, materials must have suitable mechanical toughness, biocompatibility,
appropriate biodegradability, and be clinically-compliant. In addition, due to the
avascular nature of human cornea, the permeability and hydration state of material are
essential to facilitate cell growth, nutrient transport and metabolite discharge (eg.
glucose[55], proteins[56]) throughout the engineered cornea. Moreover, material
transparency is critical since cornea provides approximately two-thirds of the total optical
power and is therefore responsible for a recipients’ normal vision [57]. Commonly used
biomaterials broadly include natural and synthetic polymers. While natural polymers tend
to have excellent biocompatibility, synthetic polymers enable customisation of desired
properties. The characteristics of extant materials determine their application (Table 1.1
and 1.2). For engineering all parts of cornea, processed collagen and silk are superior over
other materials, due to more optimal mechanical properties, transparency and
biocompatibility. For corneal epithelial and endothelial engineering, the tissues are
normally reconstructed on 2D substrates that are suitable for tissue regeneration and
15

transplantation, whilst corneal stromal cell-encapsulated 3D scaffolds are applied for
stromal engineering, as a result of the anatomical characteristic of human cornea.
Overall, collagen showed superior biocompatibility compared to other materials for
corneal stromal engineering. More importantly, as the main component and structure of
cornea stroma, organized collagen fibres ensure suitable biophysical and biochemical
properties of cornea.
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Table 1.1. Biomaterials used for corneal bioengineering
Material

Refs

N
/
S

Processing
method

Pros

Cons

Applications

Bioco
mpatibi
lity

Transp
arency

Mecha
nical
toughn
ess

Biodeg
radabili
ty

Permea
bility

Clinical status

1
2

Collagen

59,
63,
69,
98,
102,
192

N

Crosslinking;
Collagen-vitrigel;
Compression

High
biocompati
bility from
intrinsic
RGD13

Inferior
mechanical
properties

Corneal stromal
equivalents;
Substrate for
corneal
epithelial and
endothelial
bioengineering

++++

+++

+

++++

+++

Clinical
follow-up 48
months

Silk

109,
110,
114,
118,
196

N

Evaporation;
Electrospinning

Surface
modification
or
combination
required

++++

+++

+++

+++

Animal
model

111,
113,
124,
126

N

Evaporation;
Crosslinking

+++

+++

+

++++

+++

Animal
model

Chitosan

33,
132

N

Evaporation;
Composition and
crosslinking

Composition
of other
materials
(collagen
/gelatin)
required

++

+++

++

++++

++++

Animal
model

DC1

33,
146

N

Decellularization

Insufficient
keratocyte
infiltration
and
bioactivity

Substrate for
corneal
endothelial
regeneration
and epithelial
and anterior
stromal
reconstruction

++

++++

+++

+++

None

Animal
model

SS2

121

N

Coating;
evaporation

Easilybiofunction
alized;
Favourable
biocompati
bility;
Controllabl
e
biodegrada
bility
Similar
mechanical
and optical
properties
to natural
cornea;
Low
immunogen
icity
High
biocompati
bility

Corneal stromal
equivalents;
Substrate for
corneal
epithelial cells;
corneal
fibroblasts and
corneal
endothelial cells
Substrate for
corneal
endothelial cell
transplantation
and corneal
stromal cell
growth
Substrate for
corneal
epithelial
regeneration
and delivery
and for
endothelial cell
growth

++

Gelatin

Inherent
optical
clarity;
Controllabl
e
degradation
rates and
mechanical
properties
Natural
biocompati
bility;
Suitable
biodegrada
bility

Inferior
mechanical
property

+++

None

++

None

None

In vitro

Fibrin/
Agarose

221

N

Polymerization

Excellent
optical
properties

Complicated
process

+++

++++

None

None

None

In vitro

PVA3

178

S

Crosslinking;
Electrospinning

Sufficient
mechanical
properties

+

+

None

++

None

In vitro

PHEMA4

158

S

Crosslinking

Favourable
transparenc
y

Surface
modification
required;
Unsatisfied
light
transmittance
Surface
modification
required

Substrate for
human corneal
limbal epithelial
cell
Keratocytes
encapsulated
corneal stroma
equivalent
Substrate for
corneal
epithelial and
stromal
regeneration
and delivery
Substrate for
limbal epithelial
cells

+

++++

++++

+

None

In vitro

Inferior
mechanical
properties
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PEGDA5

155,
156

S

Crosslinking

PLGA6

157,
172,
176

S

Evaporation

PEG7/PA
A8
hydrogel

159,
160

S

Polymerization
and crosslinking

PGS9

164

S

Polycondensation

PEUU10

177

S

Electrospinning

Thermoresponsiv
e
materials

147,
149,
151

S

Graft;
coating

PA11

188,
189,
191

S

Self-assembly
(in solution and
coating)

Controlled
biochemica
l
and
topographic
al cues;
low relaxed
swelling
ratios
High
transparenc
y

Surface
modification
required

Substrate for
corneal
epithelial cells;
epithelial
wound healing

Nne

None

None

None

None

In vitro

Surface
modification
required

+

++++

None

+++

None

In vitro

High
transparenc
y and
glucose
permeabilit
y
Favourable
biodegrada
bility
Excellent
biodegrada
bility

Complicated
process

Substrate for
corneal
endothelial
regeneration
Corneal stroma
and epithelial
reconstruction

++

++++

++

++

++++

Animal
model

++

None

None

None

+++

None

++

None

None

++++

None

In vitro

Generate
carrier-free
cell sheet
without
enzymatic
digestion
Versatile
and easily
designed
biocompati
bility and
structure

Generated
cell layers are
too fragile for
surgical
manipulation

Substrate for
human corneal
epithelial cells
Substrate for
corneal stromal
cell growth and
regeneration
Substrate for
corneal
endothelial
sheets and
epithelial sheets

++

None

None

None

None

Animal
model (Cell
sheets)

Design 2D and
3D structures
for corneal cells
and improve
cell
performance

++++

None

None

+++

None

Animal
model

Complicated
process
Complicated
process

Complicated
process

1

Decellurized Cornea 2 Silk sericin 3 Poly(vinyl alcohol) 4 Poly(2-hydroxyethyl methacrylate) 5 Polyethylene (glycol)
Diacrylate 6 Poly(lactic-co-glycolic acid) 7 Poly(ethylene glycol) 8 Poly(acrylic acid) 9 Poly(glycerol sebacate) 10
Poly(ester urethane) urea 11 Peptide amphiphiles 12Naturally/Synthetically derived 13Arginine-glycine-aspartic acid
“++++” stands for the highest level while “+” the lowest
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Table 1.2. Biomaterials and cell sources used for corneal bioengineering for each cellular
layer.
Materials
Silk fibroin
Silk fibroin membrane[106][108][113]
Porous silk fibroin membrane[117][203]
Patterned silk fibroin membrane[165]
Silk sericin[120]

Epithelium

Collagen
Type I collagen gel[59][63][98][102]
FNC1[58]
CV2[60][86][100]
Collagen/Silk gel[97]
Synthetic hydrogel
PHEMA3[154]
PEGDA4[155][156]
Decellurized Cornea [33][34]
Chitosan[33]
Hydroxyethyl chitosan[146]
Thermoresponsive polymer
PNIPAAm5[147]
Electrospun scaffold:
PLGA6[152][172][176] PHBV7/Gelatin[124]
Chitosan/Collagen[141] PCL8/PVA9[178]
Gelatin/PLLA10[177]

Cell sources
Human epithelial cells:
Primary human corneal limbal epithelial
cells
[48][60][81][86][88][95][96][102][106][1
08][113][117][120][134][142][154][165][
173]
Primary human corneal epithelial cells
[81][87][94][102][155][156][164][167]
[203]
Immortalized human corneal epithelial
cells
[58][63][64][70][87][97][98][142][161][1
63][165]
Immortalized human
epithelial cells[166]

corneal

limbal

Animal epithelial cells:
Primary rabbit corneal limbal epithelial
cells
[59][130][176][179]
Primary
rabbit
cornea
cells[146][153][178]

epithelial

Primary bovine corneal epithelial cells[33]
Primary porcine
cells[165]

Stroma

Silk fibroin:
Porous silk fibroin membrane [118][196]
Patterned
silk
fibroin
membrane
[109][110][114][171]
RGD11 functionalized silk film [110][118]
Collagen:
Type I collagen[69][102][105]
Insoluble Type I collagen[105]
CV[60]
PEUU12[177][194][195]
Gelatin hydrogel [124][126]
DC13[133][134]
PLDLA14 [168]
Electrospun scaffold:
PHB15/PHBV/PCL[175]
PEUU[177]
Gelatin/PLLA[178]
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corneal

epithelial

Human stromal cells:
Primary human corneal stromal stem cells
[124][177][183] [203][207]
Primary human corneal fibroblasts
[62][66][102][134][186][187][188][194]
Primary human corneal keratocytes
[63][95][104][105][165][171]
Immortalized human corneal keratocytes
[87][109][110][1114][168][189]

Animal stromal cells:
Primary rabbit corneal stromal cells

[119][1126][130][135][153][175][178][20
7]
Primary rabbit corneal stromal stem
cells[124]
Primary
rabbit
corneal
fibroblasts[124][161]

Endothelium

Full-thickness

Gelatin hydrogel[123][125][127]
Gelma[129]
Thermoresponsive polymer:
PNIPAAm[149]
Poly (NiPAAm-co-DEGMA)16[151]
PNIPAAm hybrids[170]
Poly(NGMA)17[150]
PVME18[152]
Chitosan[144]
HECTS19[145]
PCL-Chitosan[143]
Silk fibroin[111]
Aloe vera gel/SF[115]
DC[136]
Compressed collagen[68]
Silk fibroin[39]
Fibrin[57][221]
Collagen gel:
Type I collagen[64]
Type I and type III collagen [55]
Collagen I and copolymer
[90][91][92][93] [95]
CV[61]
DC[130][131][139][140]
PEG20/PAA21 hydrogel [159][160]
PHEMA/PAA hydrogel [158]

1

stromal

Other animal corneal stromal cells
Goat[170];
Feline[201];
Bovine[161]
Human endothelial cells:
Primary human corneal endothelial cells
[87][111][123][127][129][136][149][183]
Immobilized human corneal endothelial
cells
[68][87][95][111][151][152]
Animal cells endothelial cells:
Primary rabbit corneal endothelial cells
[60][115][125][130][144][145][150][157][
207]
Primary bovine
cells[143][169]

corneal

endothelial

Human umbilical cord blood endothelial
progenitor cells[138]
Dorsal root ganglion (DRG) cells:
from
chick
embryos[98][118][126][203]
from mice embryos[134]
Human embryonic stem cells (hESCs)
[140]

Fibronectin-collagen; 2 Collagen-vitrigel 3 Poly(2-hydroxyethyl methacrylate); 4 Poly(ethylene
glycol) diacrylate; 5 Poly(N-isopropylacrylamide); 6 Poly(lactide-co-glycolide); 7 Poly(3hydroxybutyrate-co-3-hydroxyvalerate); 8 Poly(ɛ-caprolactone); 9 Polyvinyl alcohol; 10 Poly-L-lactic
acid; 11 Arg-Gly-Asp; 12 Poly(ester urethane) urea; 13 Decellurized Cornea; 14 Poly(L,D lactic acid); 15
Polyhydroxybutyrate; 16 Poly(N-isopropylacrylamide-co- diethyleneglycol methacrylate; 17 Poly(Nisopropylacrylamide-co-glycidylmethacrylate); 18 Poly(vinyl methyl ether); 19 Hydroxyethyl
chitosan; 20 Polyethylene glycol; 21 Poly(acrylic acid)

1.3.1 Collagen
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Table 1.3. Collagen used for corneal bioengineering
Collagen Type

Ref.

Year

In vitro study

In vivo study

Bovine type I
collagen

Processing
method
Dehydrothermal
crosslinking

88

1999

None

Bovine type I
collagen
Bovine
collagen Type I
Bovine type I
collagen and
type III
collagen.
Porcine type I
collagen

Dehydrothermal
crosslinking
Dehydrothermal
crosslinking
Glutaraldehyde
crosslinking;
EDC 1/NHS 2
crosslinking
EDC/NHS
crosslinking

63

2004

67

2006

64

2006

Primary human corneal epithelial
cells (Limbus and centre) and
human corneal fibroblasts
Primary human corneal Stromal
fibroblasts
Primary human corneal stromal
fibroblasts
Immortalized human corneal
epithelial cells

66

2006

None

Bovine
collagen Type I
Recombinant
human
collagens types
I and III

EDC/NHS
crosslinking
EDC/NHS
crosslinking

99

2007

56

2008

Immortalized human corneal
epithelial cells
Immortalized human corneal
epithelial cells

Rabbits and
minipigs
by lamellar
keratoplasty
None

Recombinant
human
collagens types
I and III
Rat tail type I
collagen

EDC/NHS
crosslinking

71

2008

Immortalized human corneal
epithelial cells

Rats by selective
lamellar
keratoplasty

EDC/NHS
crosslinking

96

2008

None

Type I porcine
atelocollagen;
Recombinant
human
type III
collagen
Type-I collagen
solution

EDC/NHS
crosslinking

93

2009

Primary cornea limbal epithelial
cells; primary human Keratocytes;
immortalized human endothelial
cells;
Immortalized human corneal
epithelial cell line
and dorsal root ganglia

Collagen-vitrigel

61

2009

None

Recombinant
human
collagen, type
III

EDC/NHS
crosslinking

192

2010

Primary human limbal epithelial
cells; Primary bovine keratocytes;
Rabbit corneal endothelial
cells
None
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None
None
None

Mini-pigs by
deep
lamellar
keratoplasty

Rabbits by deep
lamellar
keratoplasty

24-month followup of a phase 1
clinical study

Type I porcine
atelocollagen

EDC/NHS
crosslinking

94

2010

Immortalized human epithelial cell
line and dorsal root ganglia

Rat tail type I
collagen

Dehydrothermal
crosslinking

87

2010

Primary human limbal epithelial
stem cells and stromal keratocytes

Rat tail type I
collagen
solution
Rat-tail type I
collagen

Dehydrothermal
crosslinking

60

2011

Rabbit limbal epithelial cell

Dehydrothermal
crosslinking and
plastic
compression
Coating

100

2012

Primary human corneal endothelial
cells;
Human corneal endothelial cell line

None

2

2013

Immortalized human corneal
epithelial cells

None

EDC/NHS
crosslinking
EDC/NHS
crosslinking
EDC/NHS
crosslinking

39

2014

None

95

2014

98

2014

Primary human corneal epithelial
cells
Primary human corneal epithelial
cells
Human corneal epithelial cells

Bovine Type I
atelocollagen

Collagen-vitrigel

113

2015

None

Rat collagen
type I

Dehydrothermal
crosslinking

23

2015

Rat collagen
type I

Dehydrothermal
crosslinking

73

2016

Pig keratocyte;
Primary human limbal epithelial
cells
None

Rat collagen
type I

74

2017

Human corneal epithelial cells and
human corneal ketrtocytes

Bovine type I
collagen

Dehydrothermal
crosslinking and
compression
Dehydrothermal
crosslinking

76

2018

Bovine type I
collagen

EDC/NHS
crosslinking

72

2018

Bovine corneal epithelial and
endothelial cells, bovine corneal
keratocytes
Human corneal epithelial cell line

Bovine type I
collagen
Porcine type I
collagen
Bovine type I
collagen

Dehydrothermal
crosslinking
Glutaraldehyde
crosslinking
Dehydrothermal
crosslinking

77

2018

Primary corneal keratocytes

Rabbits by
lamellar
keratoplasty
None

78

2018

Human corneal epithelial cell line

None

79

2019

Primary human corneal keratocytes

None

Fibronectincollagen
treatment
Bovine type I
collagen
Bovine type I
collagen
Bovine type I
collagen
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Pigs by
penetrating
keratoplasty
Rabbits by
selective lamellar
keratoplasty
None

None
Rabbits by
lamellar
keratoplasty
Rabbits by
lamellar
keratoplasty and
LSCD 3 model
induced by
chemical injuries.
None

Rabbits by
lamellar
keratoplasty
None

None

Bovine type I
collagen

Dehydrothermal
crosslinking

80

2019

Differentiated human corneal
keratocytes from human turbinate
derived mesenchymal stem cells

Rabbits by
lamellar
keratoplasty

1-Ethyl-3-(3-dimethylaminopropyl)-carbodiimide; 2 N-hydroxysulfosuccinimide; 3 Limbal stem
cell deficiency

Collagen is the most abundant component of extracellular matrix (ECM) in most tissues
[58, 59], with tripeptide arginine-glycine-aspartic acid (RGD) recognized by cell surface
integrin receptors, being important for cell adhesion, migration and proliferation. [60].
The widespread application of collagen (especially collagen type I) in tissue engineering
is partly due to its ease of production. Collagen type I is a key component to tendon,
ligament and dermis and is relatively cheap to derive. Collagen is therefore vital to
fabricating biomimetic corneal stroma equivalents as the main component of human
stromal tissue [61-63], and is compatible with all corneal cells and nerve regrowth in vivo
[60, 64-67]. The primary drawback of collagen, however, is insufficient mechanical
toughness and elasticity [68, 69]. Therefore, crosslinking collagen has been widely
applied to considerably improve mechanical strength and chemical stability without
compromising the biological advantages. Importantly, the source of collagen impacts on
the physical properties of the final product. For instance, the addition of soluble
tropocollagen improves transparency and strength [70], and while both type I and type III
collagen hydrogels have adequate tensile strength and elasticity for handling, type III
collagen hydrogels tend to be mechanically and optically superior [56, 71].

The methods which have been investigated for collagen crosslinking for bioengineering
mainly include chemical, physical and enzymatic approaches. Aldehydes such as
formaldehyde and glutaraldehyde, the carbodiimide family (EDC) , isocyanate chemical
family (hexamethylene diisocyanate) and genipin are commonly used for chemical
23

crosslinking of collagen [72, 73]. Physical crosslinking involves ultraviolet or
dehydrothermal treatment and enzymatic crosslinking with transglutaminase can enhance
the mechanical toughness of collagen without generating toxic by-products [72, 74, 75].
However, not all of these methods are commonly employed in corneal bioengineering,
with some approaches generating toxic residues in the collagen-based biomaterial. Unlike
glutaraldehyde, hexamethylene diisocyanate and acyl azide which act as chemical
‘‘bridges’’ between collagen molecules, with EDC, collagen molecules are linked directly.
Genipin is a cross-linker with low toxicity [76]. A study of various crosslinking methods
demonstrated the inclusion of generated 2-polypropyleneimine octamine dendrimers that
largely amplifies the quantity of amine groups in collagens available for EDC
crosslinking. The membrane produced had superior optical and mechanical properties
compared with dehydrothermally and glutaraldehyde crosslinked collagen gels [64, 7781]. Another study of collagen suggested that while ultraviolet (UV) light induced
riboflavin, crosslinking or the use of genipin, or EDC crosslinking produced adequate
tensile strength; superior strength was found using the EDC crosslinking group [82].
Another crosslinking method involves UV-induced glucose, resulting in collagen
membranes with moduli and ultimate tensile strength comparable to that of native human
cornea [70]. The modulus of human cornea ranges from 0.15 to 7 Mpa depending on the
age and other conditions of donors [83-85]. While collagen scaffolds produced by most
of these methods were able to either emulate or achieve the lower end of the modulus
range of native human cornea, CV (0.69~8.69 Mpa) [86] showed a much higher modulus
(DHT: ~0.1MPa[76, 87], Glutaraldehyde: ~0.1MPa [64], EDC/NHS: ~0.1MPa [56, 64,
70]).Normally, crosslinked collagen gel can be produced in a membrane form that is
suitable as a growth substrate for corneal cells [65] and biomimetic corneal equivalents
[61, 62], or three-dimensional (3D) structures with stromal cells encapsulated or scaffolds
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seeded with epithelial and endothelial cells [88, 89]. The latter provides for the
development of full thickness corneal tissue that is analogous to a native structure, but
has relatively poor mechanical properties due to incomplete crosslinking and cell
protection [88, 89]. The cyto-compatibility of crosslinked collagen gels has been
demonstrated in numerous studies. For example, dehydrothermally crosslinked, EDC and
glutaraldehyde crosslinked gels are able to support the growth of human and rabbit
corneal epithelial cells, human corneal fibroblast, and human corneal endothelial cells [60,
63, 65, 67, 88, 90]. In addition to pure collagen hydrogel, collagen-polymer composites
have been reported to further enhance mechanical strength and resistance to enzymatic
degradation [91, 92]. For example, porcine type I collagen and 2-methacryloyloxyethyl
phosphorylcholine (MPC) interpenetrating network hydrogels display improved
mechanical strength, and stability, with comparable optical properties, and glucose as well
as albumin permeability with those of the native human cornea [93, 94]; enabling
regeneration of corneal cells and functional nerves in pig models. Combination of
collagen

with

a

copolymer

from

N-isopropylacrylamide,

acrylic

acid

and

acryloxysuccinimide resulted in a transparent, permeable and robust collagen gel that
prevented excessive collagen fibrillogenesis and was well tolerated in dogs[91]. A
composite collagen-chitosan membrane demonstrated better mechanical toughness and
optical properties, and when transplanted in pig cornea, allowed the regeneration of
epithelium, stroma and nerve in 12 months [68, 95]. The incorporation of chondroitin
sulfate into collagen gels tends to lead to higher mechanical properties and moisture
retention [90, 96]. Crosslinking tobramycin into collagen, a novel antibacterial collagen
membrane with excellent antibacterial effect can be obtained [87]. The incorporation of
cyclodextrin in collagen membrane is capable of improving the transparency as a result
of reduced collagen fibrogenesis [97]. Enhanced mechanical properties can also be
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achieved by the integration of silk fibroin [98]. Duan et al reported that incorporation of
YIGSR (a model cell adhesion peptide) modified dendrimer into collagen gel promoted
the adhesion and proliferation of human corneal epithelial cells as well as neurite
extension from dorsal root ganglia [99]. While most collagen structures reported are flat,
Zhang et al. recently produced natural corneal shaped collagen membrane by placing
dethermally crosslinked collagen in a rigid contact lens mould and then incubating at 37℃
for complete dehydration [82]. By loading a compressive force on dehydrothermally
crosslinked collagen gel, plastic compression (PC) collagen with improved mechanical
toughness has been explored as a carrier to expand human corneal endothelial cell for
transplantation [100]. The PC collagen films, however, are not easily manipulated. To
solve this issue, electrospun PLGA films were then used to form a sandwich-like structure
for transplantation. The light transmittance of the structure, however, is insufficient, being
less than 80% under 500 nm wavelength [75]. Other composites include collagen-vitrigel
(CV), a collagen-based product with enhanced gel strength by vitrification [101]. Briefly,
a mixture of collagen, FBS, N-2-hydroxyethylpiperadine-N0-2-ethansulfonic acid buffer
(HEPES) and Dulbecco’s Modified Eagle Medium (DMEM) was incubated at 37oC and
5% CO2 for 2 h gelation. Under controlled humidity, the gel was vitrified into a glasslike material. Finally, the CVs were rehydrated to obtain a regenerated and stable collagen
vitrigel membrane. During the whole process, CV can be tailored for transparency and
mechanical strength by optimizing synthesis conditions [86]. Moreover, CV has been
shown to facilitate epithelial layer generation in vitro [61], and exhibits sustained tissue
transparency and low inflammatory response [101].

To date, collagen is the most extensively used material in corneal bioengineering (Table
1.2). Overall, collagen scaffolds, either pure or hybrid, provide excellent support of cells
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derived from different corneal tissue layers. The main challenge for tissue engineers
using collagen for corneal bioengineering is the fabrication of collagen constructs that
mimic the well organised structure and cell-encapsulation ability of corneal stroma [102].
Griffith et al created a multilayered corneal matrix by seeding epithelial cells and
endothelial cells on the top and bottom of immobilized human corneal keratocytesencapsulated glutaraldehyde crosslinked collagen–chondroitin sulfate substrate [88].
Similarly, German et al. reconstructed cornea by seeding primary human corneal
epithelial cells on primary human fibroblasts-encapsulated dehydrothermally into a
crosslinked collagen gel. After 3-days in culture, 4-5 layers of regenerated corneal
epithelium and components of basement membrane were detected [103]. Keratocytes
have been incorporated into porous collagen sponges by crosslinking and lyophilisation
[104]. Keratocytes migrated into pores and evidences of matrix secretion and elongated
cell morphologies were observed. Controlling the organization of collagen fibrils to
mimic corneal stroma has long been of interest when utilizing collagen for corneal
bioengineering. Builles et al reported that scaffolds of orthogonal lamellae composed of
aligned collagen fibrils can be formed by the gelation of collagen in a horizontal magnetic
field, mirroring the inner structure of human corneal stroma. [105, 106]. Interestingly,
keratocyte alignment is directed by the collagen orientation both on the surface and within
the bulk of the scaffold [106]. Though the scaffold possesses similar structure with human
cornea stroma, it is not transparent; probably due to the relatively large diameter of
collagen fibrils. Proteoglycans were thus incorporated into the scaffold to improve the
transparency. Although as-prepared scaffolds demonstrated great potential for the
recovery of anterior cornea in a rabbit model, the graft retention, however, was still
needed to be improved by the optimization of crosslinking [106].
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1.3.2 Silk
Silk fibroin (SF) is a structural protein derived from the cocoon of the silk worm bombyx
mori and has been widely used in tissue engineering and regenerative medicine because
of its non-immunogenic response, controllable degradation rates and mechanical
properties. Normally, pure silk solution, the precursor of diverse SF framework, is
obtained by mixing SF with lithium bromide solution before dialysis. In the context of
corneal engineering the inherent optical clarity of SF undoubtedly makes it a promising
candidate. SF membranes have largely been investigated as substrates for corneal
epithelial cells. Pure and permeable SF membrane generated by simple evaporation [107]
or electrospinning [108] is able to support the formation of confluent multilayered
epithelium and growth of human corneal limbal epithelial (HCLE) cells similar to
amniotic membrane (AM) - the current standard substrate used for corneal epithelial cell
transplantation. Although pure SF membrane provides for similar cell attachment of
HCLE cells to tissue culture plastics, it is inferior to AM due to the lack of natural ECM
proteins [109]. Nevertheless, the RGD sequence present in collagen can be coupled on
the surface of SF membrane to enhance attachment and proliferation of HCLE cells,
human corneal fibroblasts (HCFs) [110, 111], and human corneal endothelial (HCEN)
cells [112] by mediating cell-substrate adhesion interactions. Interestingly, poly-D-lysine
(PDL) provides comparable support to modified RGD [113]. For corneal stromal
bioengineering, porous silk film has been shown to support the construction of a twolayer structure using human corneal limbal epithelial cells and stromal cells [114], and
human corneal stromal stem cells (hCSSCs) while secreted ECM adhered on the material.
[115]. Moreover, enhanced cell viability and well-maintained morphology of rabbit
corneal endothelial (rCEN) cells have been reported with incorporation of natural aloe
vera (AV) gel with SF [116]. To improve molecular permeability and biodegradability,
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porous SF structures were prepared using the porosity inducing agent poly(ethylene
glycol) (PEG). The porous structure induced by PEG, however, tends to reduce the growth
and stratification of Human limbal epithelial cell (HLEC) growth. It is also noteworthy
that by having high porosity the membranes tend to be more fragile [114, 117, 118].
Nonetheless, implanted RGD functionalized SF films have been shown to keep their
integrity and transparency for half a year without immunogenic and neovascular
responses in rabbit stroma [119] and notably a faster degradation rate can be achieved by
the introduced porosity [115] or combining with propionamide [120].

While fibroin has been extensively investigated in corneal engineering, another protein
from the domesticated silkworm silk sericin (SS) has been consistently overlooked due
to suspected allergenic activity. Recent interest, however, in the biocompatibility of SS
has resulted in its consideration as a cell growth substrate. Pure or blended SS membrane
showed inferior mechanical properties, but enhanced HCLE attachment compared with
SF, suggesting a potential application for corneal epithelium regeneration [121]. Recently
Applegate et al innovatively published a silk photo-crosslinking method using flavinmononucleotide (FMN), which is a water soluble variant of riboflavin, to transform silk
solution into a highly elastic and transparent hydrogel. The materials involve in the
process are all biologically and environmentally friendly, which makes this technique
very promising in corneal bioengineering [122].

Overall, compared with collagen, the advantage of using silk is mainly due to the
simplicity of production and modification, as well as the ease of patterning and preparing
the porous structure, which profoundly impacts the cell behaviour of all corneal cells. The
depth and width of grooves, for instance, were found to affect human corneal fibroblast
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alignment. Moreover, building a multilayered corneal structure using stacked patterned
porous silk films or sponge provides a useful 3D model, in spite of the technique requiring
further improvement; with native cornea consisting of approximately 200 lamellae with
a total thickness of 500 microns while the stacked silk films have far less layers [123].
While chemical surface modification has been investigated to improve the
biocompatibility, further research is necessary since the proteins in natural cornea are
varied and multifunctional. Most of the studies to date have focused on the correlation
between surface pattern and porous structure, with further studies of in vivo performance
(including the influence of porosity and patterning on biocompatibility) being necessary.

1.3.3 Gelatin
Gelatin is a ubiquitous natural material derived through hydrolysis of collagen. The
application of gelatin for corneal engineering mainly involves constructing membranes
for corneal cells through crosslinking. The applied methods to prepare gelatin hydrogel
generally include dehydrothermal and chemical crosslinking. Being dehydrothermally
crosslinked, gelatin is able to provide sheets with better transparency, elastic modulus,
and albumin permeability compared with collagen. In addition, primary human corneal
endothelial cells seeded on as-prepared gelatin showed normal expression levels of ZO1, Na+ / K+ -ATPase, and N-cadherin, and achieved a continuous endothelial monolayer
[124]. Mimura et al reported on a chemically crosslinked gelatin using glutaraldehyde
which was able to support rabbit fibroblast, fibroblast precursor adherence and ECM
deposition, and was suitable for implantation to a rabbit stromal pocket [125]. Using
EDC/NHS crosslinking and freeze-drying, gelatin membranes with varying porosity,
Young’s modulus and swelling ratio can be prepared by varying the concentration of
gelatin and crosslinking parameters [126]. Compared with pure gelatin, the incorporation
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of chondroitin sulfate (CS) has been shown to promote the growth of primary rabbit
corneal keratocytes. The hybrid gelatin-CS gel, however, had lower Young’s modulus and
resistance against protease digestion [127]. By adding heparin during EDC crosslinking,
Niu et al. prepared an innovative transparent gelatin scaffold that has the capacity to
enhance basic fibroblast growth factor (bFGF) absorption and release kinetics [128].
Furthermore, the scaffold is sufficiently flexible to be folded for easier transplantation
and HCEN cells can be grown on the scaffold while maintaining their endothelial
morphology and critical pumping function. Following transplantation in rabbits, the
implanted scaffolds gradually fuse with surrounding stroma [128]. Lai reported a 3D
culture system for rabbit corneal keratocytes (RCKs) using hyaluronic acid (HA)
functionlized gelatin microspheres that supported the large-scale growth of RCKs.
Investigation of the biocompatibility of microcarriers indicated compatibility with rabbit
corneal epithelial, stromal, and endothelial cells, and they were well tolerated in the
anterior chamber of the rabbit eye [129]. Semisynthetic Gelatin methacrylate (GelMA)
has been increasingly used in tissue engineering due to its biocompatibility and more
importantly, tunable physical characteristics produced through radical polymerization in
the presence of a photo-initiator. Rizwan et al developed hybrid crosslinked GelMA
hydrogel (GelMA+) by incubating prepolymer solution at 4oC for 1 h before UV
crosslinking (Figure 1.5). The GelMA+ showed superior mechanical properties due to
smaller and more uniform distribution of pores and excellent support of human corneal
endothelial cells. GelMA+ films seeded with HCECs and transplanted in a rabbit model
were associated with high cell viability following transplantation [130].

31

Figure 1.5. Schematic diagram of the fabrication of regular gelatin methacrylate (GelMA)
and GelMA with hybrid crosslinking (GelMA+) [130].

1.3.4 Decellularized cornea
Decellularized cornea (DC) has shown potential for corneal scaffold fabrication due to
the similar mechanical and optical properties when compared with natural cornea [131,
132] and has low immunogenicity [133, 134]. The shortage of suitable corneal tissue as
a requirement for human DC remains a limiting factor and therefore most studies have
employed porcine cornea or bovine cornea as source material. Previous studies have
revealed the feasibility of using DC to support corneal cell growth in vitro and to facilitate
tissue regeneration in animal models [135-137]. Conventional approaches to decellularize
cornea tissue involve removal of the cellular component using non-ionic detergent (eg.
Triton X-100, Sigma, St. Louis, MO, USA), ionic detergents (eg. sodium dodecyl
sulphate [SDS] and SD), zwitterionic detergent (eg. CHAPS), freezing–thawing, and
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osmotic shock with hypotonic or hypertonic solutions [132, 137, 138]. Comparison
between Triton X-100, SDS, SD and CHAPS revealed SDS to be most effective for the
removal of cellular components., Furthermore, 0.5% SDS was the most optimal
concentration for cell removal while preserving collagen ECM [132, 138]. Another study
of decellularization using Triton X-100, liquid nitrogen, and poly(ethylene glycol),
sodium dodecyl sulfate (SDS) and sodium chloride (NaCl) with nucleases found only
NaCl/nucleases completely removed the cellular component and supported the growth of
fibroblasts and epithelial cells while maintaining the integrity of corneal epithelial
basement membrane [135]. Hashimoto et al. described a novel decellularization method
using high-hydrostatic pressure (HHP) without detergents. The advantages of HHP
include the elimination of bacteria and viruses, and the preservation of collagen that
provides relatively better mechanical support [139]. Similar to the HHP method, Huang
et al reported a gentle physical decellularization method using supercritical carbon
dioxide (SCCO2), with less processing time, lower cost and elimination of pathogen to
prepare acellular porcine cornea. Compared with the Triton treatment, the use of SCC02
enabled better removal of proteins with no immune response in a rabbit model at 6 months
follow-up. Importantly, the maximum load of DC is reduced because of the increased
spaces between collagen fibrils due to the decreased GAG contents [140]. A final
decellularization method worth noting employs pancreatic phospholipase A2 (PLA2) and
SD. This approach preserves proteoglycans and the structure of native corneal stroma
while removing most of the xenogenetic cells [133].

By preserving the corneal structure, DC can provide excellent functionality with similar
optical and mechanical properties to native cornea with the capacity to support the
confluent growth of corneal epithelium, keratocytes, and endothelium, as well as the
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ability to degrade slowly while merging with surrounding stroma during regeneration of
corneal epithelium and nerve growth [131, 136]. By co-culturing limbal epithelial celllike (LEC-like) cells and corneal endothelial cell-like (CEC-like) cells derived from
human embryonic stem cells (hESCs) on the two sides of decellularized porcine scaffold,
a full-thickness artificial cornea substitute with similar thickness and mechanical
properties to native rabbit cornea was successfully constructed, with multilayered
epithelium-like cells and a uniform monolayer of CEC like cells observed. The thickness,
endothelial cell density, and mechanical properties of the construct were similar to that of
native rabbit corneas. Scaffolds could be integrated in a rabbit model with restoration of
transparency at 8-weeks follow-up, indicating DC to be a promising substrate for fullthickness corneal bioengineering [141].

1.3.5 Chitosan
Chitosan is deacetylated chitin, and is an abundant naturally derived polymer. For corneal
bioengineering, chitosan has primarily been employed as a substitute for AM as a cellcarrier to reconstruct the ocular surface or endothelium. It has been reported that primary
bovine corneal epithelial cells (BCEs) seeded on pure chitosan membrane showed
improved proliferation and attached more quickly than those on AM. Moreover, pure
chitosan membrane is able to preserve the phenotypes of BCEs similar to AM [142].
Furthermore, chitosan surface modification can have a positive effect on generating a
monolayer of human corneal epithelial cells while non-modified substrates cannot [143].
For endothelial regeneration, chitosan membrane with controllable biodegradation rates
can be obtained by incorporating polycaprolactone (PCL), a slow degrading synthetic
polymer. Bovine corneal endothelial cells (BCECs) cultured on this blended membrane
showed normal appearance, proliferated well, forming a continuous monolayer [144]. In
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addition to serving as a potential substrate for human corneal epithelial cells, the
incorporation of chitosan can promote the optical transparency and mechanical strength
of collagen membranes[95]. Because of the poor solubility of chitosan in physiological
solvents, the research focus has been shifted to hydroxyethyl chitosan (HECTS), a watersoluble derivative of chitosan. With comparable optical transparency, water content, and
higher glucose permeability compared with natural human cornea [145, 146], membranes
made up of hydroxypropyl chitosan, gelatin and chondroitin sulfate can improve the
growth of human corneal epithelial cells and RCEN cells, promote the growth of primary
rabbit corneal epithelial cells and corneal epithelium restoration in vitro, and are tolerated
well in the anterior chamber of an in vivo rabbit model.[145-147]. Although chitosan has
demonstrated great potential for corneal bioengineering, it is more suitable to be utilized
as blended scaffolds, rather than pure.

1.3.6 Thermal responsive polymers
Stimuli responsive polymers such as poly(N-isopropylacrylamide) (PNiPAAm) and
PNiPAAm-based copolymers are being increasingly used in bioengineering because of
their thermoresponsive hydrophobic and hydrophilic properties, which enable the
detachment of cell sheets without the use of enzymatic digestion. The ability to generate
carrier-free cell sheets makes it a promising technique for corneal epithelium and
endothelium engineering. While several publications support the use of both corneal
epithelium [148] and endothelium cell sheets [149] derived from temperature responsive
substrates, endothelium construction has attracted most interest. Using rabbit limbal
epithelial stem cells isolated from a rabbit ocular surface, corneal epithelial sheets with
compact multilayered cell sheet architecture were successfully generated from PNiPAAm
grafted cell culture surfaces using poly(vinylidene difluoride) (PVDF) membrane and
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applied for autologous transplantation. The cell sheets attached to exposed rabbit corneal
stroma within minutes without suturing and successfully reconstructed the corneal
epithelium [148]. The structure and function of HCEN cell sheets detached from pure
PNiPAAm are able to restore corneal clarity without causing inflammation or rejection in
rabbit models [149, 150]. The activity of Na+, K+-ATPase and existence of pump sites
were confirmed in vitro and more importantly, proper stromal hydration was found and
corneal clarity was gradually restored in a rabbit model [149, 150]. Apart from pure
PNiPAAm, copolymerization with glycidyl methacrylate (NGMA) allows manipulation
of the critical temperature and comprises epoxy groups for the incorporation of
biomolecules. The use of a copolymer of N-isopropylacrlamide (NiPAAm) and
diethyleneglycol methacrylate (DEGMA) enables faster cell detachment with a critical
temperature, closer to the physiological range [151, 152]. Teichmann et al reported a
thermal responsive carrier using poly(vinyl methyl ether) (PVME) where layer thickness,
stiffness, switching amplitude and bioactive modification can be coordinated to regulate
initial immortalized human corneal endothelial cell adhesion and detachment of cell
sheets [153]. Despite all the advantages, given the thermally detached cell monolayers
are usually fragile, the use of compatible delivery methods is important for surgical
manipulation of sheet grafts. Various carriers have thus been investigated for the delivery
of constructed epithelial (PVDF) [148] and endothelial layers (Stroma bed and Gelatin)
[149, 150].

1.3.7 Other synthetic polymer hydrogels
A variety of synthetic materials including poly(vinyl alcohol) (PVA) [154], poly(2hydroxyethyl methacrylate) (PHEMA) [155], polyethylene (glycol) Diacrylate (PEGDA)
[156,

157],

poly(lactic-co-glycolic

acid)
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(PLGA)

[158]

and

poly(ethylene

glycol)/poly(acrylic acid) (PEG/PAA) based hydrogels [159-161] have also been applied
in corneal bioengineering, as either substrates for corneal cells or artificial cornea
substitutes. While exhibiting excellent permeability, controllable mechanical and optical
properties, all of these materials display poor cell-adhesive function without surface
modification [162]. For example, to improve the attachment and growth of primary rabbit
and human corneal cells, electrospun PVA, PHEMA hydrogel and PEGDA hydrogel were
modified with collagen type I, phosphate groups and RGD, respectively [154, 155, 163].
Moreover, hydrogels functionalized with amine can support epithelization using human
corneal epithelial cells [162]. Similarly, collagen type I coated PLGA films can better
serve as substratum for rabbit corneal endothelial cells [158]. Artificial cornea fabricated
using ZnS/PHEMA/PAA hydrogel demonstrated high refractive index [159] and
PEG/PAA hydrogel showed high glucose permeability, while remaining optically clear in
situ for up to 2 weeks [160, 161]. Recently, poly(glycerol sebacate) (PGS), a novel
biodegradable elastomer, was cured into films and capable of maintaining the viability of
HCE cells. However, there have been no reports of the mechanical or optical properties,
or in vivo testing to date [164].

1.4 Material surface modification for corneal bioengineering
Material surface modification for corneal bioengineering includes topographical and
chemical modification. Common methods such as surface pattern, RGD and collagen
coatings are employed to impact the morphology, attachment, proliferation, and
differentiation of varied kinds of corneal cells, as well as improve the biocompatibility of
scaffolds. More details will be included below.

1.4.1 Topographical modification
The influence of topographical cues and surface chemical modification are important for
cell support regardless of the tissue type being engineered [165, 166]. For topographical
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modification, the most commonly used technique to create varied patterned features is
soft lithography [115, 130, 165, 167-172]. Briefly, feature-patterned master moulds (for
instance, patterned silicon substrates), are covered with PDMS, cured on the patterned
substrate and then removed to be used as patterned templates for cell seeding.
Anatomically, for corneal epithelial engineering, the key findings are that human corneal
epithelial cells contact guidance is not only modulated by the scale of the topographical
cues [165] but, also, human corneal limbal epithelial cells seeded on patterned silk created
by lithographic techniques suggest that parallel line patterned surfaces promote initial cell
attachment by 36–54% and more that 2-fold increase in focal adhesion (FA) localization
[167]. In addition, the adhesion and proliferation rate of human corneal epithelial cells on
collagen film can be promoted by inducing a micro-rough surface using a freeze-drying
technique [168]. Interestingly, for corneal stromal bioengineering, whilst both depth and
width of grooves influence HCFs alignment, the former appears to play a more critical
role for cell orientation [115]. On poly (L,D lactic acid) (PLDLA) electrospun
nanofibrous substrates, human corneal stromal cell orientation and differentiation can be
directed, with stiff and orthogonally arranged nanofibre layers resulting in keratocyte-like
morphology other than those of HCFs [169]. Nara et al. employed direct-write assembly
(DWA) and prepared parallel patterned thermo-responsive substrates that can guide goat
corneal keratocytes alignment. However, these patterned substrates could not produce
complete sheet restoration [171]. To compare the effect of different topography on
endothelial cells, various kinds of patterns including channels, gratings, concentric
circles, wells and pillars have been studied. Bovine corneal endothelial (BCEN) cells
grown on pillars provide a lower coefficient of variation of area, enhanced Na+/K+ATPase activity and a density of microvilli similar to native cornea compared to other
patterns [170]. Similar findings on Human corneal endothelial cells reported by Rizwan
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et al showed that higher Na+/K+-ATPase expression was found on the substrates of squarearray and hexagonal-array of 1 mm pillars with 6 mm spacing compared to flat substrate.
Specifically, square-array topography increased ZO1 and Na+/K+-ATPase expression
higher while hexagonal-array induced more favourable cell morphometry such as high
cell densities, low cell areas and homogenous cell size, thus improving the quality of the
regenerated HCEC monolayer [130].

Apart from stereo lithography, the effect of topographical modification on corneal cell
growth and subsequently corneal tissue regeneration can be explored via noteworthy
fabrication techniques, namely electrospinning. Electrospinning is a widely investigated
fibre fabrication method that applies a voltage between a syringe and a collector to draw
fibres from polymer solutions dispensed by the syringe [173]. Electrospun scaffolds are
increasingly being investigated to develop biomimetic bioengineered cornea as a result
of the bionic reconstruction of ECM, which showed promotion of corneal cell adhesion,
proliferation, migration and differentiation [143, 174]. In many instances natural
materials are used including SF [108], gelatin [175], collagen [143], hyaluronate (HA)
[143]) and synthetic polymers PCL [176], PLGA [177], RGD (PEUU) [178], Poly-L/Dlactide (PLDLA) [169], Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) [176],
with the latter characterized by outstanding mechanical properties. While the use of
natural materials is limited by inferior mechanical toughness and therefore handling for
surgery, synthetic polymers such as FDA approved PLA, PLGA, and PCL have been
employed extensively. The application of electrospun scaffolds is primarily limited to
serve as substrates for the growth and delivery of corneal cells and the exploration of cellsubstrate interactions. Electro-spun substrate as a replacement for AM to support the
regeneration and delivery of corneal epithelium has been widely studied. For instance,
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PHBV/gelatin [174], collagen/chitosan/hyaluronate(HA)/ PEO [143], PLGA [177]
electrospun substrate has been proven as suitable substitutes for AM. Gelatin/PLLA based
substrates has been used to investigate the relationship between human corneal epithelial
cells

and

keratocytes

cell

behaviours

and

fibre

arrangement

[179].

Collagen/chitosan/hyaluronate (HA)/PEO electrospun film was characterized with
excellent mechanical properties, comparable optical and biological performance in vivo
for rabbit ocular restoration [143]. Ortega et al electrospun biodegradable PLGA fibres
onto PEGDA ring with microfeatures to mimic corneal limbus with the rabbit corneal
limbal epithelial cells well attached and proliferated on the designed microstructure [173].
Furthermore, PCL electrospun nanofibres support HCLE cell phenotype to facilitate
cornea epithelium construction and promote cell attachment of rabbit limbal stem cells
and rabbit keratocytes [176]. Notably, PLGA electrospun scaffold is not only
biocompatible with HCS cells but also capable of maintaining a keratocyte phenotype
[169] and multilayered rabbit limbal epithelial cells [177]. Apart from the choice of
material, the ease of manipulating mechanical properties, transparency and biological
properties is also determined by polymer components, special arrangement and
functionalization [179-181]. For example, the degree of alignment of fibres affects the
mechanical properties of scaffolds [179]. Aligned fibres mirror the natural configuration
necessary for cell support and differentiation [175, 182]. For instance, HCSS cells
cultured on electrospun PEUU aligned scaffolds tend to secrete collagenous matrix with
similar alignment to natural corneal stroma [178]. Similar results have shown that aligned
electrospun collagen scaffolds tend to dedifferentiate rabbit corneal fibroblasts from the
myofibroblast phenotype [181]. Salehi et al reported on an electrospun nanofibrous
PGS/PCL semitransparent substrate that was able to support the growth of human corneal
endothelial cells with hexagonal morphology, and direct human conjunctival epithelial

40

cells growing along the aligned fibres with the incorporation of PGS improving the cell
proliferation and viability [183]. Earlier studies demonstrated the potential of electrospun
scaffolds in corneal tissue formation as a result of the favourable mechanical properties,
transparency and the biocompatibility with various corneal cells. However, few in vivo
studies have been performed to date.

1.4.2 Chemical modification
Modifications with proteins, peptide and chemical groups are commonly utilized to
promote corneal cell growth. Apart from the widespread modification of RGD or collagen
on synthetic polymers, carbon chain length of amine modifications are able to impact the
attachment of epithelial cells and stromal cells [162]. A study of collagen type I, collagen
type IV, fibronectin (FN), FNC coating mix and laminin modifications indicate all these
coatings facilitate cell adhesion, with FN coating being most favourable for HCEN cell
growth and optimum compact cellular morphology [184]. Interestingly, the Chitosan
coating was also found to improve the growth of human corneal epithelial cell line [143].
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Figure 1.6. Examples of supramolecular self-assembled PA nanostructures: (A)
nanofibres; (B) micelles; and (C) multi-layered nanotapes. All three structures have an
hydrophilic outer corona comprised of bioactive peptide (blue) and self-assemblyinducing/spacer sequence (white), and an hydrophobic inner core with organized and/or
non-organized PA tails (red and green, respectively) [185].

Peptide amphiphiles (PA) are peptide-based molecules typically composed of hydrophilic
and hydrophobic domains and of great interest in tissue engineering by virtue of the
ability to self-assemble into high-aspect-ratio and highly bioactive nanostructures under
certain physical conditions (pH, temperature and ionic strength) [186]. PA generally
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comprises three components: an hydrophobic tail, beta-sheet forming amino acids, and
an hydrophilic head that promotes water-solubility and biocompatibility. Self-assembly
of PA can be guided by the hydrophobic collapse of the tail and achieved by hydrogenbonding between beta-sheet forming amino acids (Figure 1.6). More specifically,
hydrophobic tails of PA were internalised and the hydrophilic heads exposed as bioactive
interacting surfaces [187]. For tissue engineering, PA are commonly applied in different
formats, including coating, solution and hydrogel formats. For corneal bioengineering,
PA has primarily been used for coating or in solution due to the inferior mechanical
toughness of hydrogels, able to support a wide range of corneal cells [186]. As previously
mentioned, RGD has been widely coated on various biomaterials to promote corneal cell
interaction and adhesion. In this context, Gouveia at al. employed PA consisting of RGD
contained peptides as a film coating that was able to enhance adhesion, proliferation and
alignment of HCFs and enable the construction of 3D lamellar-like stromal tissue [188].
By also adding a matrix metalloprotease (MMP)-cleavable sequence, the PA not only
acted as a substrate for the attachment and growth of human corneal stromal cells in a
quiescent phenotype, but also enabled self-release after adding retinotic acid (RA) to the
culture medium to facilitate the detachment of regenerated stromal matrix from the base
[189]. In addition, Jones et al. [190] reported on a special PA: C16-KTTKS, which selfassembled into nanotape structures that were able to stimulate collagen I production from
human corneal stromal cells. Finally, Uzunalli et al. [191] applied a laminin-derived
sequence YIGSR into PA to regulate cell adhesion for corneal stroma regeneration.
Compared with RGD-PA, as-prepared PA demonstrated enhanced cell proliferation,
keratocytes migration, and collagen I synthesis both in vitro and in vivo.
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1.5. In vivo performance for corneal bioengineering
Due to their excellent intrinsic biocompatibility, collagen gels, both pure and blended
developed by various kinds of methods, have shown promising performances in vivo.
From a 24-months follow-up of a phase 1 clinical study on the EDC crosslinked collagen
gel scaffold, the fabricated implants remained stable and avascular, with corneal reepithelialisation, restored tear film, recruited stromal cells, and nerve regeneration [192].
Various hybrid collagen gels, such as collagen/chitosan [68], glutaraldehyde crosslinked
collagen/TERP [92] were well tolerated in pig corneas for 12 months and dogs for 16
weeks, respectively. Being applied as full thickness implants in the guinea pigs, the
collagen–MPC hydrogels integrated into the host corneas and promoted regeneration of
corneal tissue and nerves. Electrical activity recorded from regenerating corneal nerves
suggested that the regeneration of corneal nerves into the implant started at three months
post-surgery and the nerves were functionally active within the implant by eight months
[94].

Although surface modifications are normally necessary to promote corneal cell growth,
silk-based films have demonstrated favourable in vivo responses. RGD functionalized 5layers stacked silk implanted in the lamellar pocket at the limbus in the rabbit models can
maintain their integrity and transparency over the 180 days without causing immunogenic
and neovascular responses or degradation of the rabbit corneal stroma. The regenerated
extracellular matrix deposited and adhered well to the surface of the silk films [119].
Porous silk films prepared using PEG were inserted into stromal pockets at the limbus of
rabbits and were gradually replaced by stromal tissue corneal while stromal cells
infiltrated into the silk films without causing inflammatory reaction 6 months later.
Notably, unlike porous silk films, non-porous ones did not degrade at 6 months [107].
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Transparent blended films with aloe vera gel and SF as a carrier for corneal endothelial
cells (CECs) was developed by Kim et al by seeding RCECs on the films to reach
confluency. Transplanted into the anterior chamber of the rabbits’ eyes together, the
constructs attached well to the surface of the corneal stroma and, four weeks later, started
to integrate with the surrounding corneal tissue; with rabbit CECs firmly-adhered and
functional. Moreover, rabbit cornea transplanted using hybrid AV/SF scaffolds with
rCECs revealed a higher corneal transparency compared with those of pure SF films with
rabbit CECs; indicating the improvement of clarity afforded by the AV. However, many
constructs were difficult to insert during the transplantation surgery because of
insufficient mechanical properties [193]. An investigation on how transplantation
techniques affect biological responses of silk films in rabbits is stimulating and
worthwhile noting. Porous silk films transplanted into different locations of the ocular
surface (peripheral-median P-M, central-superficial C-S, central-deep C-D) were used to
assess the in vivo response. The in vivo response of the films was found to be dependent
on the method to create the corneal pocket, the position of the sample and sutures. To be
more specific, with the use of flushing air (instead of using a surgical blade), the CD
position (compared with P-M and C-S) and a lack of sutures resulted in less injury and
inflammatory responses. Two months after the surgery, a comparison on the degradation
of silk films with low, medium and high beta sheet (crystalline) content showed that low
beta sheet samples lost structural integrity while medium and high beta sheet content films
remained as at the initial stage [194]. Although fibroin film is designed as a transplantable
carrier, improvement in physical properties is needed to graft the sheet on a curved surface
such as the cornea.
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One common application of gelatin for corneal bioengineering is to serve as carriers for
endothelial regeneration and delivery. For instance, EDC crosslinked intact and porous
gelatin carriers have been inserted to the anterior chamber of rabbit eyes and no change
was observed on the cell morphology of rabbit corneal endothelial cells by day 3 [126,
129]. Being implanted into the anterior chamber of endothelium-removed rabbit model,
EDC crosslinked heparin-modified gelatin remained transparent by week 3 with little
surrounding intra-ocular inflammation [128]. Glutaraldehyde crosslinked gelatin seeded
with rabbit fibroblast and fibroblast precursors were transplanted into rabbits eyes with
lamellar dissection, while both carriers were well tolerated during the 4 weeks follow-up,
gelatin/precursors group showed more intense expression of ECM molecules [125].
Longer-term observations of the biological responses of gelatin used in vivo are however
limited.

Due to the well-maintained integrity of ECM, DC has demonstrated excellent
biocompatibility in vivo. Porcine cornea, decellularized using Tris-HCL [131], SDS [132],
PLA2/SD [133], HHP method [139], SCCO2 [140], have been transplanted in rabbit
corneal stroma pocket to investigate the biological responses. The implants were normally
capable of becoming completely transparent within two weeks, being maintained for at
least 12 months after transplantation with the implants being able to support a stratified
epithelium with infiltrated keratocytes. Zhang et al developed a full-thickness cornea
substitute using limbal epithelial cell-like and corneal endothelial cell-like cells derived
from human embryonic stem cells and decellularized bovine cornea. Being transplanted
into rabbit model using PK, no significantly high IOP was found in the follow-up period.
By 8 weeks, the substitutes were well integrated with corneal tissue. LEC-like cells were
completely replaced by host cells and the endothelial cell density of TECS was similar to
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that of native rabbit cornea. Compared with decellularized bovine cornea without cells,
the full thickness graft showed less neovascularization with new blood vessels only in the
periphery while its counterpart was completed invaded [136].

Research relating to the in vivo performance of chitosan is limited. It is reported that after
HECTS/CS blended membranes were transplanted into the anterior chamber of rabbits,
the cornea still retained clarity and no apparent symptoms could be detected [146]. For
corneal epithelial bioengineering, rabbit corneal epithelial cells-seeded chitosan
membranes were transplanted onto the ocular surface in rabbits, promoting corneal
recovery [147] and that the chitosan coatings were able to promote corneal epithelial
recovery in a rabbit corneal defect model [143].

While most synthetic hydrogels are applied as substrates to investigate fundamental cell
behaviours, most of them did not receive in vivo evaluation. As artificial cornea,
PEG/PAA hydrogel was able to remain optically clear and show excellent tolerance after
being sutured into stroma of rabbit for 2 weeks [160]. A comparison between
Poly(ethylene glycol) diacrylate (PEG-dA) and Poly(ethylene glycol) diacrylamide
(PEG-dAAm) hydrogel showed that in terms of vivo biocompatibility in rabbits, the PEGdAAm-based hydrogel was superior to the PEG-dA-based hydrogel, with far longer
maintenance of corneal clarity of up to 6 months while PEG-dA-based gel implanted ones
showed haze and opacity within 10 weeks [161].

1.6. The importance of cell biology in corneal bioengineering
Considering the different cell types throughout the cornea and the likely requirement of
more than one type of cell support substrate with a composite of biomaterials, there is a
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need for extensive optimisation studies towards merging the components for a complete
and functional cornea. For example, electrospun aligned PEUU substrate [178], combined
with growth factors [195] and the selection between human corneal stroma stem cells
(HCSS) cells and HCFs will result in different collagen fibril matrices and therefore
different tissue constructs. Specifically, multilayered lamellae with orthogonally oriented
collagen fibrils that accurately mimic the human corneal stromal tissue will likely require
the combination of fibroblast growth factor (FGF-2) and transforming growth factorsbeta3 (TGF-b3). Both of these growth factors can stimulate the secretion of collagen from
cells resulting in directional growth of collagen fibrils and orthogonal fibril orientation of
a collagenous layer [195]. Regarding cell choice, Human Corneal Stromal Stem (HCSS)
cells should differentiate into keratocytes and secrete multilayered lamellae with wellorganized collagen fibrils, while HCF cells are more likely to differentiate into fibroblasts
and generate a less-organized collagen construct [196]. Similar results can be expected
for porous gelatin hydrogel based constructs, with fibroblast precursors likely to be better
candidates for corneal stroma engineering compared with fibroblasts because of higher
collagen I expression in vivo after implantation [125]. Moreover, the use of serum tends
to induce human corneal stromal cells to become fibroblastic. In contrast, a keratocytelike morphology arises in the absence of serum [169]. Compared to culturing human
corneal epithelial cell and stromal cells alone, co-culturing both cells demonstrated
improved differentiation and growth for both of the cells [197]. A study on the influence
of serum concentration, oxygen tension for incubation, and macromolecules
(carrageenan)-supplemented media on extracellular matrix deposition in human corneal
fibroblast culture interestingly found that the low oxygen tension coupled with
supplemented media in culture significantly promoted extracellular matrix deposition at
day 14 [198].
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Practically, the use of seeding cells to differentiate or modulate the local tissue
environment, thereby promoting regeneration and repair, remains a logical progression
for research. A breakthrough on corneal epithelial regeneration using tissue-engineered
cell sheets composed of autologous oral mucosal epithelium offered a new treatment for
ocular trauma or disease. After scar tissues on the ocular surface were removed, cell sheets
constructed by culturing oral mucosal tissue from patients on temperature-responsive
polymer poly(N-isopropylacrylamide) were transplanted to patients’ eyes. Excitingly,
complete re-epithelialization was detected within one week in all treated eyes and corneal
transparency was restored and well maintained through long-term follow up (mean period
of 14 months) [199]. Yang et al previously showed that human amniotic epithelial cells
could differentiate into conjunctival epithelium-like cells and goblet cells with partially
physiological function thereby providing successful restoration of ocular surface integrity
in a rabbit model of conjunctival disease [200]. More directly, Mathan et al successfully
isolated and transplanted sphere-forming cells from the peripheral cornea for the potential
use of targeting in-vivo ocular surface regeneration and stem cell repopulation [201]. Yet
challenges remain. Understanding the detailed mechanism of differentiation induced by
the niche, the method of immortalization of differentiated cells and the physiological
functions of tissue-engineered surfaces is essential for long-term success. The
microenvironment appears to play an important role in the directional differentiation and
fate of the implanted cells [202]. As evidence, Mathan and co-authors found that corneal
repopulation differed from scleral cell repopulation. The authors hypothesized that
inherent characteristics within cells may lead to preferential changes (i.e. a cell derived
from the limbus would like to reform a limbus or limbal niche). Separately, the authors
found sphere implantation indicated a similar reactive biological response to the
wounding process. Regardless, current findings provide tangible evidence to support
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long-held theoretical beliefs. The concurrent use of biomaterials may provide additional
benefits, and further research is essential to optimizing an effective approach to corneal
tissue regeneration.

1.7 Electro-compaction of collagen (ECC)
Since the first report on electro-compaction of collagen [203], this technique has been
widely explored on various biomedical applications, such as tendon [204], neurite [205],
cornea [206] and cardiomyocyte [207] (Table 1.4). Among these studies, tendon has
received the most attention and it has been reported that genipin-crosslinked ECC tread
was able to achieve comparable mechanical properties to native canine tendons [208],
induce tenogenic differentiation of human mesenchymal stem cells [209] and demonstrate
favourable biodegradability in vivo in rabbit [210]. By mixing with peptidoglycan [211],
the mechanical properties of ECC scaffolds can be significantly enhanced. For corneal
application, Vipuil et al has showed that EDC/NHS-crosslinked ECC membrane can
support the proliferation of primary corneal keratocytes[206].
Its unique ability to produce condensed and mechanically enhanced collagen structure
has prompted us to explore the application of ECC on corneal epithelial bioengineering
(Chapter 3 and 4). Ensuing characterisation of constructs revealed the relationship
between the directions of aligned collagen fibres and applied current; further revealing
the enormous potential of ECC for developing biomimetic collagen stromal models
(Chapter 5 and 6).
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Table 1.4 Electro-compaction of collagen
Year
Application
2008[203] Tendon/ligament
2008[212] None

Form
Tread
Membrane

2009[213] None

Membrane

2010[204]
2011[214]
2011[211]
2011[210]
2011[205]

Tread
Tread
Tread
Tread
Tread

Tendon
None
Tendon
Tendon
Neurite

2012[215] Cornea (Immobilized
MK/T-1 cells from
mouse corneal stromal
cell culture)
2012[208] Tendon
2012[209] Tendon
2014[216] Tendon
2015[217] Human mesenchymal
stem cells
2016[207] Cardiomyocyte/skeletal
muscle
2016[206] Corneal stroma

Membrane

2017[218] None
2018[219] Skin

Tread
Membrane

Tread
Tread
Tread
Tread/
Membrane
Membrane
Membrane

Parameters
6V
5~10V (0.7~-1.2
mA/cm2)
8V (15~60
mins)
None
20V
20V (12h)
12V
~3V (30~60
mins)
8V (30
mins)

Crosslinker
Genipin
None

20V
20V (6h)
None
5A/cm2

Genipin
Genipin
Genipin
Genipin

25V
(4mins)
3V
(45mins)
20V (60s)
6V
(15mins)

EDC/NHS

None
Genipin
None
None
Genipin
None
None

Genipin;
EDC/NHS
Genipin
EDC/NHS

1.8 Conclusion and aims of the thesis
Over the past few years, many different types of bioengineered substitutes have been
developed to address the shortage of qualified corneal donors. Biomaterials used are
largely limited to natural polymers able to support cell growth and function in vitro, and
tissue regeneration in vivo. Collagen, the main component of human cornea, remains the
best candidate in part due to its excellent biocompatibility from intrinsic RGD, with the
main challenges in the biomimetic fabrication of aligned collagen fibrils mirroring
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corneal stromal inner structure. Silk has shown excellent optical clarity and more
importantly, controllable degradation rates and mechanical properties, unlike other
natural polymers. In terms of pursuing cell-biomaterial interactions, the ease of patterning
and chemical modification enables silk to outweigh other materials. Derived from
collagen, gelatin does not show any better overall performance. Alternatively, chitosan is
easily-functionalized and highly biodegradable and could be more useful when it acts as
an incorporated component in blended scaffolds. Despite their excellent physiological
properties, modification of synthetic polymers (e.g. RGD, collagen addition) is required
to achieve satisfactory biological performance. Notwithstanding, they have significant
potential as artificial cornea or substrates for various kinds of corneal cells, with most of
the candidates mentioned above showing favourable ability to support the growth and
delivery of diverse cell types.

In spite of the progress and promise of bioengineered cornea, there are many challenges
to overcome. Firstly, human trials are necessary to definitively determine the efficacy of
corneal substitutes. Currently, clinical trials of bioengineered corneal substitutes are byand-large limited to collagen-based materials with other materials rarely reported [18,
192]. A 12-month follow-up of limbal stem cell therapy and long-term corneal
regeneration conducted on 113 eyes of 112 patients with burn related limbal stem cell
deficiency showed that the total success rate by one year, as characterized by a transparent,
avascular, and stable corneal surface being restored, was 76.6% [220]. A significant
finding is that a minimum number of 3000 p63-bright holoclone-forming limbal stem
cells is essential and suggested for clinical success of autologous limbal stem cell
transplantation [220]. Most bioengineered substitutes are merely designed to fulfil the
requirements of transparency, biocompatibility and biodegradability, with other
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important properties such as innervation and regeneration often overlooked. Corneal
innervation is critical to corneal sensation and protection, with optimal nerve density
important for wound healing. Notwithstanding, some studies have demonstrated the
reinnervation of collagen-based grafts in vivo [56, 91-94, 192], but reports on neural
regrowth of other materials remain limited. Notably, Wang et al. recently developed
innervated silk-based multilayered corneal epithelium and stroma; including innervation
that was induced and directed by nerve growth factor (NGF) in vitro. Increased IVL,
GJA4, ALDH3A1 and KERA expression of innervated models indicated better corneal
epithelial maturity and corneal stromal transparency compared to non-innervated ones;
which further demonstrated the key role of innervation on the maintenance of corneal
epithelium and stroma (Figure 1.7) [221].
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Figure 1.7. Schematics of human cornea and an in vitro 3D corneal tissue model. Scale
bars = 3mm.[221]

Then, while a great number of studies have reported on the effect of the characteristics of
scaffolds (composition, structure, pattern and etc.) on in vitro response, few were carried
out on the influence of those on the in vivo response, which might be more significant
when pursuing the best substitute for corneal tissue. The use of a porous structure [115]
or combining propionamide [120] , for instance, tends to induce a faster biodegradation
rate in an animal model. Lastly, recognition of the structural distinction of different cornea
tissue layers has underscored the need for a variety of strategies to develop substitutes
amenable to generating each layer. Despite the challenges, progress is being made
towards identifying efficacious and accessible substrates capable of supporting cell
growth and delivery, and tissue restoration towards recapitulating bona fide corneal tissue.
The most challenging aspect of corneal tissue research, as has always been, and is the
fabrication of stroma consisting of parallel lamellar sheets and a highly ordered
microstructure of collagen fibrils with functional keratocytes and proteins to mimic the
cornea stroma; as a result of the anatomical and functional importance of stroma. Once it
is achieved, bioengineering whole thickness cornea should be much easier since
substantial progresses have been claimed on the regeneration of cornea epithelium and
endothelium which are mainly cell layers. Engineering corneal substitutes with all layers
for full-thickness, the PKP procedure would be preferable. Currently, protocols to
fabricate whole-thickness cornea are cell-free and cell-encapsulated membranes.
Recently, electrochemically compacted collagen matrices with improved strength and
modulus after being crosslinked by EDC/NHS or genipin demonstrated highly dense
structure and comparable transparency to native cornea, suggesting great potential for
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corneal tissue engineering [206]. Apart from collagen gel, human keratocytes
encapsulated into fibrin–agarose scaffolds with similar transparency, and UV absorption
characteristics to native human cornea [57, 222], have been built into whole cornea by
seeding corneal epithelial cells and endothelial cells on each side [223]. Zhang et al
recently developed a biomimetic 3D corneal model by loading patterned silk films and
collagen gel onto a dome-shaped post and more interestingly, the effect of mechanical
strain on human keratocytes phenotype and extracellular matrix formation investigated
(Figure 1.8). The keratocytes alignment and ECM arrangement were directed by the
topography of the silk films and, compared with traditional 2D culture, higher expression
of keratocytes marker and expression of ECM were detected in the 3D model. Moreover,
higher expression of keratocyte marker was also observed on 3% dome-shaped
mechanical strain cornea model compared with flat-shaped strain [172]. Gouveia et al
successfully fabricated auto-generated scaffold-free 3D corneal equivalents by stacking
human corneal stromal cell sheets collected from PA coatings and subsequently culturing
the multilayered cell sheets for 21 days. The corneal equivalent was not only transparent
but also well integrated into rabbit models after 9 months. Some interesting findings
include that the alignment of stromal cells and secreted collagen fibril are directed by the
topography of the template; with cells grown on anisotropic ones generating aligned
collagen fibrils that assembled significantly thicker, denser, and were more resistant to
proteolytic degradation than those of cells and secreted fibrils on a non-anisotropic pattern.
This work is definitely significant for fabricating a scaffold-free human tissue that mimics
corneal stroma with controlled structure and functional properties [224].
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Figure 1.8. The synergistic effects of topography and mechanical strain on keratocyte
behaviour in a biomimetic 3D corneal model. A) Schematic for the biomimetic 3D corneal
model using patterned (600 grooves mm–1) silk fibroin films, collagen I hydrogel, and
3% dome-shaped strain [225].
Given the findings of the literature survey, to fill the gap in current research efforts, this
thesis, therefore, aims to explore the potential of ECC on corneal bioengineering,
including utilizing an ECC membrane for corneal epithelial engineering and more
importantly, building a biomimetic 3D stromal model. Chapter 2 describes the
experimental procedures and techniques routinely used throughout the work. Chapter 3
includes the fabrication of an ECC membrane and the morphology, mechanical properties
and water content of the ECC membrane were studied and compared with those of NECC
(None electro-compacted collagen). The light transmittance, and glucose permeability of
the ECC membrane were also investigated. In chapter 4, human corneal epithelial cells
were seeded on both ECC and NECC to investigate cell viability, proliferation and
attachment. Chapter 5 presents a robust biomimetic stromal model consisting of
orthogonally aligned collagen fibrils and primary human corneal stromal cells (hCSCs).
The collagen structure was confirmed by SEM. Moreover, the light transmittance, glucose
permeability and stability were monitored in culture medium for up to 2 weeks. Chapter
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6 further confirms the biomimetic structure of the as-prepared stromal model by F-actin
staining and evaluates the viability, proliferation of encapsulated hCSCs. The effect of
aligned collagen fibrils and 3D stromal model on the expression of keratocytes markers
and fibroblasts/myofibroblasts markers of hCSCs was then investigated using qPCR.
Finally, based on the recent published studies and the present thesis, a conclusion and
future outlook are outlined in Chapter 7.
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2.1 Introduction
This section includes the materials, instruments and procedures used in this thesis. It
primarily comprises of electro-compaction of collagen and characterizations. Also
included are details on the culture of human corneal epithelial cells and primary human
corneal stromal cells. More details are presented in the experimental section of each
chapter.

2.2 List of chemical reagents and materials
Table 2.1 Chemical reagents and materials
Reagent name
Type I bovine collagen

Source
Cat NO
Advanced [9007-34-5]
BioMatrix,
Inc.
Sigma
E1769

EDC (N-(3-Dimethylaminopropyl)-N′ethylcarbodiimide
Hydrochloride)
Sulfo-NHS (N-Hydroxysulfosuccinimide
sodium salt)
PBS tablet

Sigma

56485

Sigma

P3813

Dulbecco's Modified Eagle Medium:
Nutrient Mixture F-12
(DMEM/F-12)

Invitrogen

11330-032

DMEM/F 12 no red

21041025

Penicillin/Streptomycin

Life
Technologi
es
Life
Technologi
es
Life
Technologi
es
Gibco

Albumin bovine serum

Sigma

A3059

PrestoBlue™

Invitrogen

A13262

Calcein AM

Invitrogen

C3099

Propidium iodide (PI)

Invitrogen

P3566

TrypLE™ Select Enzyme
Basic fibroblast growth factor
(bFGF)
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12563029
13256029
15140122

Fetal Bovine Serum

Interpath

SFBSN2

Triton X-100

Sigma

T8532

Donkey serum

Merck

S30

D-glucose

Sigma

G8270

Goat serum

Sigma

G9023

Anti-KERA antibody produced in
rabbit

Sigma

HPA03932131573

Monoclonal Anti-Actin antibody, αSmooth Muscle from mouse

Sigma

A2547

Alexa Fluor 488 anti-rabbit lgG(H+L)
antibody from donkey

Invitrogen

A21206

Alexa Fluor 594 anti-mouse lgG (H+L)
antibody from donkey

Life
A21203
Technologi
es
Invitrogen D1306

4, 6-diamidino-2-phenylindole
(DAPI)
Glucose assay kit

Sigma

GAGO20

Ethylenediaminetetraacetic acid
(EDTA)

Ajax
FineChem

180

KI67 antibody (mouse)
Prolong Diamond antifade
PDMS

Invitrogen
Invitrogen
SILOPREN
UV-LSR
(13NLVL1
79T)
SILOPREN
UV-LSR
(13HLVT
400)
Life
Technologi
es
Bio-rad
Bio-rad
Life
Technologi
es
Sigma

334711
P36965
MOMENTIVETM

Photo-initiator

Insulin-Transferrin-Selenium-X
Supplement (100X)
Aurum™ Total RNA 96 Kit
iScript RT Supermix, 100 rxns
SYBR® Select Master Mix

Primer-Thy-1 (THY-1)

MOMENTIVETM

51500056

7326800
1708841
4472897

Forward:
ATGAACCTGGCCATC
AGCATCGC
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Primer-Aldehyde

dehydrogenase

3 Sigma

(ALDH3)

Reverse:
CGAGGTGTTCTGAGCC
AGCAGGC
Forward:
ACTCAGCAGGACGAG
CTCTAC
Reverse:
GGGTCACAGAGGATG
TAGTC

Primer-Alpha-smooth muscle actin (α- Sigma

Forward:

SMA)

CCGTGATCTCCTTCTG
CATT
Reverse:
CTGTTCCAGCCATCCT
TCAT

Primer-Eukaryotic 18S (18s)

Sigma

Forward:
CGGCTACCACATCCAAG
AA
Reverse:
GCTGGAATTACCGCG
GCT

2.3 General synthesis and preparation
2.3.1 Electro-compaction of collagen
Collagen is the major component of extracellular matrix (ECM) in most human tissues
[1]. Structurally, collagen molecules consist of three α chains that are composed of amino
acids (Figure 2.1). The molecules then assemble into collagen firbils (10 to 300 nm in
diameter) that aggregate to form collagen fibres (0.5~3um in diameter). The widespread
application of collagen in tissue engineering is due to its excellent biocompatibility, but
also partly impeded by its poor mechanical toughness [2]. Recently, it has been reported
that collagen molecules can be electro-compacted by applying a certain voltage on
80

collagen solution [3, 4]. Briefly, due to the ampholytic nature, collagen molecules in pH
gradients generated by electrolysis of water demonstrate different charges in different
regions, resulting in aggregation of molecules at the isoelectric point (Figure 2.2). In this
study, we assembled an electro-compaction device comprising of two electrode plates
and a PDMS rim as spacer (Figure 2.3). After loading collagen solution, a certain potential
was applied using CHI electrochemical workstation with current change monitored over
time (Figure 2.2).

The connections to working, counter and reference leads are

demonstrated in Figure 2.3. After compaction, the resultant membranes were either crosslinked using EDC/NHS (Chapter 3) or incubated with PBS (Chapter 5) before using.

Figure 2.1. (a) Schematization of a collagen α chain triple helix segment. (b) Assembled
tropocollagen molecules. (c) Collagen fibril ranging from 10 to 300 nm in diameter. (d)
Aggregated collagen fibrils forming a collagen fibre with a diameter ranging from 0.5 to
3 μm [5].
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Figure 2.2. Schema of electro-compaction device (left) and image of electrochemical
workstation (right).

Figure 2.3. Connections to leads of EC device (W: working electrode; C: counter
electrode; R: reference electrode).

2.3.2 Preparation of conventional collagen gel
Two types of conventional collagen gel were prepared in this study. The first type
(Chapter 3) was chemically cross-linked collagen gel prepared by mixing collagen and
the cross-linker (EDC/NHS) and incubating at room temperature. The other one (Chapter
5) was prepared using a conventional dehydro-thermally cross-linking method by
changing the pH of the collagen solution before gelling at 37 °C.
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2.3.3 Laser cutter
Laser engraving systems by Universal Laser Systems (Figure 2.4) was used to prepare
nylon rims (nylon membrane filters from Whatman LOT: D112754) and acrylic rims for
the fabrication of the corneal stromal model. A 10.6µm laser was used for all cutting with
speed 55% and intensity 25% for nylon membrane and speed 2.4% and intensity 25% for
acrylic.

Figure 2.4. Photo of the Laser engraving systems by Universal Laser Systems.

2.3.4 Fabrication of corneal stromal model
Firstly, nylon rims were labelled using tweezers to indicate the direction (red arrow) of
aligned collagen fibrils and loaded into the compaction device (Figure 2.5). The electrocompaction was then conducted and the EC membrane was incubated with PBS before
using. After seeding with hCSCs (human corneal stromal cells), 2D EC membranes were
superimposed over one another with collagen fibrils orthogonally arranged to construct a
3D model, mimicking the structure of native human corneal stroma.
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Figure 2.5. Photo of nylon rim-loaded EC device.

2.3.5 3D printing of PDMS rim
A 3D plotter system manufactured by EnvisionTEC was used to print PDMS rims. Ink
containing PDMS and photo-initiator was homogeneously mixed using an ARE-250
mixing and degassing machine from THINKY and loaded into the cartridge (Figure 2.6)
and printed on a Petri dish. After that, the rim was immediately cross-linked until fully
cured using a UV lamp (100 Watt, OmniCure, SERIES 1000) at 365nm at 100 % intensity
for 300s.

Figure 2.6. Photo of 3D plotter system manufactured by EnvisionTEC.
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2.3.6 Critical point drying
Critical point drying is an efficient way to process water–containing delicate biological
samples for SEM observation, due to its ability to prevent structure damage that comes
from surface tension when transferring from the liquid to gaseous state. Before criticalpoint drying, biological samples were first fixed and rinsed with a series concentrations
of ethanol from 30% to 100%. After that, liquid CO2 was applied as transitional fluid to
substitute the ethanol in samples through serial dilution steps. Then, CO2 was transformed
into its gaseous phase, without crossing the phase boundary between liquid and gas,
before coating the samples for SEM analysis. In this study, a Leica CPD030 Critical Point
Dryer was used for hydrated collagen samples drying.

Figure 2.7. Photo of Leica CPD030 Critical Point Dryer.

2.3.7 Sputter coating
Sputter coating generates a controlled and thin coating on samples by electrically
charging a cathode. In this study, the ejected Au particles with argon are deposited on
dried collagen samples to achieve enough conductivity for SEM observation. The sputter
coating was performed in a Dynavac Sputter Coater (Figure 2.8). The Au plate as cathode
was placed on the top of the chamber with samples on the substrate below. Then, the
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chamber was degassed and refilled with Ar. The sputtering was carried out at a pressure
from 2.0 to 2.3×10-3 Pa.

Figure 2.8. Photo of Dynavac Sputter Coater.

2.4 Cell culture
2.4.1 Cell culture of human corneal epithelial cells (HCECs)
Immortalized HCECs (SV40-Adeno vector transformed corneal cells from RIKEN
BioResource Centre Cell Bank) were maintained in incubators (5% CO2, 37°C) in 25cm2
culture flask (Greiner bio-one, 690170). Cells were passaged when achieved 70~80%
confluence after being incubated with 0.25% Trypsin for 3 min. A 1:5 split was then
conducted for subculture.
2.4.2 Isolation and cell culture of primary human corneal stromal cells (hCSCs)
Human corneal tissue obtained from the NSW tissue bank was used for hCSC isolation,
as approved by the Human Research Ethics Committee of NSW South Eastern Sydney
Local Health District (HREC ref no: 15/251) and the Human Research Ethics Committee
of University of Wollongong/Illawarra Shoalhaven Local Health District (HE15/483).
Briefly, the epithelium, Descemet's membrane and endothelium were sequentially
removed, and the stroma was cut into ~1 cm3 pieces. The pieces were cultured in petri
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dishes (35mm, Thermo Fisher Scientific, USA). DMEM/F12 with 5% FBS were then
dropped onto the surface of the stromal explants, followed by a 15min-incubation at room
temperature in the biological safety cabinet and then transferred into incubators for 2h.
Explants were then incubated in DMEM/F12 with 5% FBS overnight and floating
explants were removed. Stromal cells growth from the explants were observed after 2-3
days incubation. Culture medium was changed every 2 days and cells were passaged upon
reaching 70%-80% confluence and cryo-preserved at -80 oC for future use. Cells were
expanded in DMEM/F12 with 10% FBS and 1% penicillin/streptomycin. As described
previously [6, 7], cells were stabilized in serum-free medium (SFM) (DMEM/F12 1:1, 1%
(v/v) 100x Insulin-Transferrin-Selenium (ITS), 0.01% (v/v) 10M phosphoascorbic acid
and 0.01% (v/v) 100 ng/nL FGF-2) for 3 days before further use. All cell-based
experiments were performed with passage 3 hCSCs.

Figure 2.9. Photo of human corneal tissue.
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2.5 Characterization
2.5.1 Physicochemical characterization
2.5.1.1 Scanning electron microscope (SEM)
Normally, SEM generates images by detecting secondary electrons emitted by atoms
excited by a focused beam of electrons that are scanned on samples (Figure 2.10) [8].
Biological samples thus need to be processed to be conductive at the surface for the
observation. Here, prior to SEM imaging, the samples were fixed with 2.5%
glutaraldehyde, dehydrated through a series of ethanol solutions and critical point dried.
Samples were then sputter-coated with appropriate 10 nm gold coating, mounted on the
specimen holder, and visualized using a JSM-7500FA LV Scanning Electron Microscope
(JEOL Ltd, USA).

Figure 2.10. Principle of SEM.
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2.5.1.2. Rheometer
A Rheometer is a device that determines how a liquid, suspension or flows respond to
applied force. In this thesis, rheological properties of samples, including elastic modulus
and viscous modulus, were evaluated using a rheometer (AR-G2 TA Instrument).
Samples were loaded between the lower component that is fixed and the upper component
that is connected to a shaft and can rotate (Figure 2.11).

Figure 2.11. Photo of rheometer.

2.5.1.3. Mechanical tester
Tensile and compressive tests apply force (tensile/compressive) at a controlled speed to
a material and measures the specimen's response to the stress, determining the maximum
strength or load that the material can withstand. In the current study, the mechanical tests
were carried out on a Shimadzu EZ mechanical tester. A 10N force transducer was used
for all tests and the set-ups for the tests are demonstrated below.
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Figure 2.12. Photos and set-ups of mechanical tester.

2.5.1.4. Diffusion experiment
Diffusion is the random movement of molecules through a barrier driven by a
concentration gradient (from high to low). In the case of an in vitro diffusion experiment,
a permeant passively moves from the donor chamber, through an artificial or biological
membrane into a receptor chamber. In this thesis, a standard side-by-side diffusion
chamber was applied to investigate the glucose permeability of collagen membranes
(Figure 2.13).

Figure 2.13. Schema and digital images of diffusion chamber.
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2.5.1.5. UV-Vis (Ultraviolet and visible) absorption spectroscopy
UV-Vis (Ultraviolet and visible) spectroscopy is used to measure the absorption spectrum
or reflectance spectrum of a beam of light in the ultraviolet-visible spectral region after it
penetrates a sample or reflects from the surface. In this study, the resultant solution after
the reaction of glucose solution collected in the diffusion test and GO assay kit was
measured using UV-Vis to determine glucose concentration.

2.5.1.6. Weight Loss experiment
The weight loss experiment is a common experimental technique used to monitor the
weight change of scaffolds over time. In this study, the samples were incubated in culture
medium and cell culture incubator for two weeks. The dehydrated weight of samples was
determined using a Micro-Superrange balance (Figure 2.14) from SARTORIUS.

Figure 2.14. Photo of Micro-Superrange balance.

2.5.1.7. Light transmittance
Total transmittance, which includes both the light that is transmitted directly through the
sample and that is diffusely scattered, was measured in the visible light region using a
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ColorQuest XE bench-top spectrophotometer. When measuring total transmittance,
samples were placed in the transmission compartment after standardization using the
white board (Figure 2.15).

Figure 2.15. ColorQuest XE bench-top spectrophotometer.

2.5.1.8. AFM (atomic force microscope)
AFM is a type of microscope which is capable of generating pictures of sample surfaces
on the atomic level and commonly used in nanotechnology. The AFM works by
employing a cantilever with a sharp tip. When operating, the tip scans over the surface of
samples being imaged with a deflection of the cantilever caused by the change of forces
between the tip and sample. The deflection can be detected and recognized using a laser
spot which is reflected from the surface of the cantilever to a detector (Figure 2.16). In
this study, an AFM (Park Systems XE-Bio) was applied to measure the membrane
thickness at the edge of samples [4].
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Figure 2.16. Principle and photo of AFM (Park Systems XE-Bio).

2.5.2 Biological characterization
2.5.2.1. Cell viability assay
Live/Dead cells staining kit is based on calcein AM (for the staining of live cells) and
Propidium iodide (PI)(for the staining of stain dead and dying cells). In live cells, cellpermeant calcein AM which is non-fluorescent can be converted into intensely
fluorescent calcein. Conversely, PI is only able to enter dying and dead cells which have
damaged membranes, generating a bright red fluorescence by binding to DNA. In this
study, the samples were treated with calcein AM and PI at room temperature for 15 min
and then ready for observation using a Leica TSC confocal microscope.

2.5.2.2. Cell proliferation assay
PrestoBlue is used to quantify the proliferation of cells. When incubated with cells, the
PrestoBlue reagent is reduced by viable cells and turns red, which can be evaluated by
fluorescence or absorbance measurements. The scaffolds were incubated with the 1:10
(v/v) Prestoblue reagent in incubators for 30 min. The solution was then transferred into
93

a 96-well plate (Greiner bio-one, 655180) and the fluorescent intensity was evaluated by
a POLARstar Omega microplate reader. The solution reacted with samples without cells
were used as the blank.

2.5.2.3. Cell attachment assay
Cell attachment assay was conducted by quantifying the cell numbers attached on
substrates after PBS washes [9, 10]. Samples were placed in 24 well plates and received
three PBS washes. During the washes, the tip of the pipette reached the bottom edge of
wells without touching the samples and PBS was pipetted out slowly and gently in a
constant speed before refilling. The number of cells remaining attached on the samples
was then quantified using PrestoBlue reagent. The cell spreading area of substrateseeded cells was quantified using ImageJ posterior to F-actin and DAPI counterstaining.

2.5.2.4. Cell Immunophenotyping
Immunophenotyping is a common method used to study the protein expression of cells
using antibodies. In this study, samples were fixed using a 3.7 % PFA solution and then
incubated overnight at 4 ºC with PBS containing 1%BSA and 0.3% (v/v) Triton X-100.
After that, samples were incubated with conjugated antibodies at 4 ºC overnight. Samples
were then counterstained using DAPI at RT for 10 min. Samples were imaged with a
Leica TSC confocal microscope.
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2.5.2.5. RT-qPCR (Reverse transcription-quantitative PCRRT-qPCR)
RT-qPCR is a powerful tool to detect and quantify mRNA and miRNA, with data
collected in real time throughout the PCR amplification process. This method is able to
identify small differences in RNA expression levels, thus has been widely applied to
evaluate the change of gene expression associated with cell growth and differentiation. In
this study, RT-qPCR was performed in the following steps. Firstly, RNA was isolated
using AurumTM Total RNA Mini Kit and the purity was evaluated by NanoDrop™. RNA
was then transcribed to cDNA using iScript™ Reverse Transcription Supermix (Bio-rad,
1708841) and qPCR was conducted by using a SYBRTM Select Master Mix for CFX
(4472942) for 40 amplification cycles using a Bio-Rad CFX real-time instrument (Figure
2.17).

Figure 2.17. Program used for qPCR.
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Chapter 3
Fabrication and characterization of electrocompacted collagen membranes
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3.1 Introduction
Biomaterials are attracting much interest in their potential for constrcuting corneal
substitutes by providing structural and functional requirements consistent with native
cornea.[1] These include collagen,[2] silk,[3] gelatin,[4] chitosan,[5] and decellularized
cornea.[6] As the main component of cornea that makes up approximately 70% of the
total dry tissue weight,[7] collagen has been extensively studied for corneal
bioengineering and has been shown to be compatible with a diversity of corneal cell
types;[8-10] extending to in vivo animal and human modeling.[11, 12] Collagen is readily
available in large quantities due to the rapid development of isolation and purification
techniques.[13] Notwithstanding the advantages, the application of collagen-based
structures is hindered by poor mechanical properties. This has been addressed by
crosslinking the collagen[14, 15] or by combining with synthetic materials that are
mechanically stronger.[2]

Another key challenge, for bioengineering cornea using collagen, resides in fabricating
scaffolds with appropriate modulus that mimic the well-organized structure of corneal
stroma.[16] This has led to a large amount of studies aimed at the fabrication of structures
of aligned collagen fibres.[17-19] Oriented collagen scaffolds can be achieved by electrospinning, but this process involves the use of toxic and corrosive solvent.[20] Scaffolds
consisted of aligned collagen fibrils have also been fabricated by the gelation of collagen
in a magnetic field to mimic the structure of human corneal stroma. Nevertheless, teslaorder superconducting magnets are required.[19]
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Based on the principles of isoelectric focusing, more recent efforts have been underway
to produce aligned collagen fibrils, constructing scaffolds with superior mechanical
toughness and highly oriented structures [21]. Generally, due to the ampholytic nature of
collagen, when applying a certain voltage, solubilized collagen molecules exhibit diverse
charges at different locations between the electrodes because of the pH gradient generated
by electrolysis of water molecules. This leads to the compaction of collagen molecules at
the isoelectric point where net charge is 0.

Recently, ECC matrices were characterized in vitro using corneal keratocytes; with cell
viability and proliferation well maintained on the matrices.[22] However, corneal epithelial
recovery, which is essential for ocular surface health, has not been studied. Moreover, the
advantages of ECC compared to conventional collagen gel and several other significant
attributes for corneal bioengineering (glucose permeability, light transmittances and fibril
alignment) are yet to be explored.
In this chapter, ECC membrane composed of aligned collagen fibrils which was
characterized was fabricated and identified as a potential substrate for corneal
regeneration. ECC was also compared with NECC that has already shown excellent
performance in vitro and in vivo [23-26]. Moreover, the scanning electron microscopy
(SEM), mechanical properties, water content, transmittance and glucose permeability
were evaluated to examine the eligibility of ECC to serve as a corneal substitute.
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3.2 Experimental section
3.2.1 Reagents and materials
Collagen type I from bovine hides acid (Advanced Biomatrix, San Diego, CA), 1-ethyl3-(3dimethylaminopropyl

carbodiimide)

hydroxysulfosuccinimide)

(Sigma-Aldrich),

(EDC)
PDMS

and

Sulfo-NHS

(SILOPREN

(N-

UV-LSR,

MOMENTIVE), ITO glass (ITO-P001, Zhuhai Kaivo Optoelectronic Technology Co.,
Ltd.), conductive copper adhesive tape (IA027, ProSciTech), Glucose (GO) assay kit
(Sigma, GAG20).

3.2.2 Preparation of electro-compaction device
3.2.2.1 Electrodes preparation
Stainless steel plate and ITO glasses were cut into 30mm*30mm pieces and conductive
copper tapes were adhered to the corner as displayed below. The conductive side of ITO
was confirmed using a multimeter and labelled.

Figure 3.1 Digital image of stainless steel and ITO glass pieces.

101

3.2.2.2 3D printing of spacer using PDMS
The model of the spacer was designed with a similar diameter to that of native human
cornea [27] and drawn using AutoCAD software (Figure 3.2). UV-crosslinkable PDMS
was employed as the ink. Briefly, un-crosslinked PDMS and photo-initiator were mixed
in 50:1 (w/w) according to the manufacturer’s protocol and then homogenized using ARE250 mixing and degassing machine from THINKY. After that, the mixture was transferred
into the cartridge and then loaded onto the printer. For printing, previously drawn model
(stl.) was copied into the PC and converted into the format that can be recognized by the
3D plotter. PDMS rims were printed under 5.0 bar with a speed of 15.0mm/s. Electrocompaction devices were then assembled as demonstrated in Figure 3.4.

Figure 3.2 Spacer model drawn using AutoCAD software (inner diameter: 12 mm,
height: 2.5 mm).
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Figure 3.3 Digital images of EC device.

3.2.3 Preparation of electro-compacted collagen membrane and NECC membrane
3.2.3.1 Fabrication of ECC membrane
The electro-compaction of collagen was conducted according to previously published
papers [28]. Briefly, acid soluble monomeric collagen solution (6mg/ml) from bovine
hides (Advanced Biomatrix, San Diego, CA) was dialyzed against ultrapure water (18.2
MΩ cm) at 4℃ for 48h to remove salts. The resultant collagen solution was diluted to
approximately 1.5 mg/ml and injected into the two-electrode device with a stainless-steel
plate serving as the cathode on the bottom, and an ITO (Indium Tin Oxide) coated glass
plate as the anode on the top (Figure 3.3). The printed PDMS (polydimethylsiloxane) rim
was applied as the spacer. After applying 6 V for 120s, the anode and spacer were removed,
leaving the electro-compacted collagen deposited on the steel. Resultant collagen
membranes were treated with 1-ethyl-3-(3 dimethylaminopropyl carbodiimide) (EDC)
and Sulfo-NHS (N-hydroxysulfosuccinimide) (Sigma) in the mass ratio 1:5:1
collagen:EDC:NHS at pH 5.5 for 4 hours, after which the scaffolds were rinsed with PBS
(phosphate-buffered saline). Scaffolds were sterilized in 70% Ethanol prior to use.
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3.2.3.2 Fabrication of NECC membranes
The NECC membrane was prepared using a conventional method. Briefly, soluble
monomeric collagen solution was mixed with EDC/NHS, in a mass ratio of 1:5:1 of
collagen:EDC:NHS at 4°C. The mixture was then poured into a PDMS mould and
crosslinked at pH 5.5 for 4 hours, followed by PBS washing and sterilization before use.

3.2.4 Scanning electron microscopy
The SEM images were acquired using a JSM-7500FA LV Scanning Electron Microscope,
operating at 10 kV. Samples were fixed using freshly prepared 2.5% glutaraldehyde at
4°C for 2 hours. After a PBS wash, samples were dehydrated through a series of ethanol
solutions (30%, 50%, 75%, 90%, and 100%) with 10 mins for each concentration and then
critical-point dried with a Leica CPD030 Critical Pt Dryer. Samples were sputter coated
with appropriate 10 nm gold in a Dynavac Sputter Coater before observation.

3.2.5 Rheological test
Rheological measurements of the elastic modulus (G’) and the viscous modulus (G”) were
obtained on a rheometer (AR-G2, TA Instruments). The oscillatory measurements were
performed at room temperature with a cone-and-plate geometry plate (15mm in diameter,
2 DEG cone angle). Before the oscillatory frequency sweep, a strain sweep test was carried
out to ensure the tests were performed in the linear viscoelastic (LVE) range, where G’
and G” are independent of the strain amplitude.

3.2.6 Mechanical test
The mechanical properties of dried (tensile test) and wet membranes (compression test)
were determined by using a Shimadzu mechanical tester (EZ-L). Note that the fully
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swollen NECC samples were not able to be mounted for tensile test due to weak
mechanical properties. The samples for tensile test and compression test were prepared
into strips (5 mm wide and 15 mm long) and disks (15mm in diameter) using 3D printed
PDMS frames. The tensile properties were measured at a strain rate of 0.01 mm/min.
Compressive stress-strain measurements were performed at a crosshead speed of
0.1mm/min. The Young’s modulus was determined using the slope of the stress-strain
curve. All tests were performed using a 10 N load cell.

3.2.7 Water content
ECC and NECC gels were soaked in PBS for 2h. The hydrated weight was determined
using a microbalance after the surface water was gently blotted dry. The samples were
then weighed to collect dry weights after being dried at room temperature under vacuum.
All samples were tested in triplicate. Water content was defined as:
Water content = (Mass hydrated – Mass dry)/ Mass hydrated.

3.2.8 Transmittance
The colour properties were evaluated by measuring total transmittance in the visible light
region using a light ColourQuest XE (HunterLab, USA) spectrophotometer and described
using the CIE L*a*b* (CIELAB) system (1.00 in. diameter light pass, nominal
standardization). The value L* indicates the lightness ranging from white (L* = 100) to
black (L* = 0).

3.2.9 Glucose permeability
Glucose permeability studies were conducted at 37 °C using two-compartment diffusion
chambers with mechanical stirring at 100 rpm. Briefly, ECC membranes (500 μm in
thickness) were each placed between the two chambers without leaking. A glucose
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solution in PBS was loaded in one chamber and the solution in the other chamber was
collected every 30 min followed by absorbance analysis at 540nm using a glucose assay
kit (GAGO-20, Sigma-Aldrich) with a UV-3600 spectrophotometer from Shimadzu.

3.2.10 Biodegradation
ECC and NECC were incubated in PBS and the dehydrated weights were recorded at days
1, 7, 14, 21 and 28 (n = 6). The average and variance of the dry weight of all samples were
calculated. The residual mass% was calculated according to the following equation:
Residual mass% = dehydrated mass / initial dehydrated mass.

3.2.11 Statistical analysis
Experimental data were analyzed statistically using analysis of variance (n=3). The values
of probability (p-value) were calculated. P-values less than 0.05 were considered to be
significant.

3.3 Results and Discussion
3.3.1 Fabrication of ECC and NECC membrane
The collagen sheet in the shape of the printed PDMS rim was fabricated using an
electrochemically induced collagen aggregation procedure and, after being crosslinked
with EDC/NHS, the resultant collagen membrane demonstrated optical transparency,
mechanical stiffness, and water incorporation that are promising for use in corneal
bioengineering (Figure 3.5). An applied potential of 6V for 120s was found to be optimal
for electro-compaction (Figure 3.6). Higher current densities and longer process times
tend to produce bubbles on the cathode due to H2 and O2 formation, impairing the integrity
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of the collagen membrane. Conversely, a lower density avoided the electrolysis of water
which generates unwanted pH gradients and, however, cannot afford the compaction of
collagen molecules. The current density that was used here was higher compared to some
previous studies, which also in turn reduced processing time [29]. Collagen membranes
with various thicknesses can be obtained by varying the collagen concentration, which
was in accordance with the previous experience [21]. For NECC, the collagen solution
gradually gelled in the PDMS rim within 4 hours after mixing with EDC/NHS. While both
ECC and NECC gels were transparent and mechanically stable, the ECC gel was more
robust, retaining its shape when being handled by tweezers while NECC totally deformed,
which indicates that the ECC gel is easier to manipulate (Figure 3.6). The flexibility of
ECC was also demonstrated by folding the membrane using tweezers (Figure 3.7).

Figure 3.4. Current response (i-t curve) of electro-compaction of collagen.

Figure 3.5. Transparent ECC membrane with underlying characters clearly visible.
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Figure 3.6. Representative examples of handling ECC and NECC membranes. While both
gels were able to be handled with tweezers, ECC membranes retained their original shape
while NECC membranes were by-and-large deformed.

Figure 3.7. Digital images of ECC membrane being folded by tweezers.
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3.3.2 Scanning electron microscopy

Figure 3.8. SEM images showing the structural and surface topographies of ECC (A and
C) and NECC (B and D). Compared with NECC, ECC exhibited a structure with greater
alignment of collagen fibrils.

Stroma, which accounts for about 90% of the whole cornea, consists of highly organized
and aligned collagen fibrils providing for corneal strength and transparency.[30]
Constructing a collagen matrix with biomimetic structure has been and remains the major
challenge for corneal bioengineering

[19]

. Herein, the ultrastructure of ECC and NECC

membranes were analyzed by SEM (Figure 3.8). Images clearly show a difference
between collagen fibril orientation and density, with ECC membranes being more
compacted and with alignment of fibrils. The diameter of collagen fibrils of ECC and
NECC were similar (20~50nm, the scale of black lines in C and D are 100nm), and
comparable to ~30 nm diameter collagen fibrils found in the human cornea.[31] Notably,
collagen fibrils of NECC were disordered, with the arrangement of ECC fibrils
structurally more similar to native cornea, with collagen lamellae formed by aligned
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collagen fibrils.[32] Interestingly, the direction of alignment (arrows) is in accordance with
that of conductive tapes that were connected with the inputs.

3.3.3 Rheological test

Figure 3.9. Elastic modulus (filled square) and viscous modulus (open square) versus
strain of ECC (blue) and NECC (red).

A strain sweep test was carried out to ensure the tests were performed in the linear
viscoelastic (LVE) range (Figure 3.9). The effect of strain on the measured G’ and G” at
constant frequency was evaluated. It was observed that G’ and G” were independent of
the applied strain from 0.01 to 1.
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Figure 3.10. Elastic modulus (filled triangle) and viscous modulus (open triangle) versus
frequency of ECC (blue) and NECC (red).

Dynamic viscoelastic measurements of the ECC and NECC membranes were then
conducted and revealed that the storage modulus (G′) and the loss modulus (G′′) were
weakly dependent on the frequency (Figure 3.10). While both ECC and NECC displayed
a high degree of elasticity with G’ constantly greater than G” over the entire frequency
range, ECC showed a much higher G’ than NECC, suggesting superior mechanical
rigidity. A pilot study reported significant increase of tensile strength after crosslinking of
electro-compacted collagen matrices using EDC.[33] The comparison between EDC
crosslinked ECC and NECC, however, was not studied.
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3.3.4 Mechanical test

Figure 3.11. Tensile stress–strain curve (A) and compressive stress–strain curve (B) of
ECC (blue) and NECC (red).

The stress-strain curves of ECC and NECC were also compared (Figure 3.11). Electrocompaction did not only result in increased compressive and tensile fracture strength, but
also greater than 10-fold enhancement of compressive and tensile modulus. The
compressive and tensile moduli were calculated from the slope of the stress–strain curve
from 0 to 0.1 strain. The improvement derived from electro-compaction is attributed to
the alignment of collagen fibrils that mimics the structure of human cornea. In native
human cornea, the aligned and condensed collagen fibrils provide mechanical stiffness to
the tissue [27]. Importantly, the compressive modulus of ECC displayed a value of
approximately 0.3 Mpa (Figure 3.12), which is close to that of native human cornea;[34]
therefore making ECC a promising candidate for corneal tissue engineering.
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Figure 3.12. Compressive modulus and tensile modulus of ECC (blue) and NECC (red).

3.3.5 Water content, transmittance and biodegradation

Figure 3.13. Total transmittance of EC and NECC at 400-700nm.
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Figure 3.14. In vitro degradation of ECC and NECC matrices against PBS.

Table 3.1. Colour attributes and water content of ECC and NECC.
L*

a*

b*

Water content

ECC

94.68±0.07

0.174±0.001

0.184±0.042

86.1±2.5%

NECC

94.15±0.07

-0.020±0.001

-2.538±0.056

90.4±1.3%

The light transmittance at 400–700 nm through ECC and NECC was measured to
characterize the transparency. The total transmittances of ECC and NECC membranes
were generally similar in the wavelength range, with values fluctuating between 85% and
90% (Figure 3.13). ECC appears to be more transmissible at the high wavelength region
(500~700 nm) while NECC showed higher values at the low wavelength region (400~500
nm). Table 3.1 shows the colour properties of the ECC and NECC. ECC demonstrated
slightly higher L* values than NECC (P<0.05), which indicates higher luminosity. This
little increase may be explained by the theory that the alignment of collagen fibrils ensures
optical clarity of the collagen matrix,[35] which is in agreement with the SEM results.
Besides, all ECC showed positive a* and b* values, while negative numbers were detected
for NECC, suggesting the presence of red and yellow in ECC while green and blue for
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NECC. The transparency of human cornea is maintained by regulating its water content.
[33] The stroma, as the main structure of cornea, is normally about 75% water by weight.
[34] The water content of ECC (86.1±2.5%) was significantly lower than that of NECC
(90.4±1.3%) (P<0.05) (Table3.1), but remained higher than that of human cornea. This
may relate to the formation of tightly aligned collagen fibrils forming a relatively dense
structure that causes a decrease in water content. Biodegradation rate in PBS was
conducted to evaluate the influence of electro-compaction on matrix stability. As shown
in Figure 3.14, at day 28, the residual mass was 95% for ECC and only 86% for NECC,
indicating that electro-compaction improves the stability of collagen matrices in PBS.

3.3.6 Glucose permeability
The standard curve of glucose concentration was firstly determined by preparing the
solutions as shown in Table 3.2. The reaction was started by adding 2.0 ml of Assay
Reagent and allowing a 30 minutes reaction at 37 °C, before adding 2.0 ml of 12 N H2SO4.
The resultant solution was carefully mixed thoroughly (Figure 3.15) and its absorbance
measured against the reagent blank at 540 nm.
Table. 3.2 Formulae of samples for determination of standard glucose concentration curve.
Sample

Water (ml)

Glucose solution from kit (ml)

Blank

1.00

---

S1

0.98

0.02

S2

0.96

0.04

S3

0.94

0.06

S4

0.92

0.08
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Figure 3.15. The colour of resultant samples after GO assay reaction deepened with
sample collecting time.

Figure 3.16. A linear increase of absorption at 540 nm with glucose concentration.

The permeability coefficient (P [cm/s]) was calculated using the following equation
(Eq.3.1) [36, 37]:
𝑑𝑑𝑑𝑑

𝑃𝑃 = (

𝑑𝑑𝑑𝑑

. 𝑉𝑉)/(𝐴𝐴. 𝐶𝐶0.60)

Eq.3.1

where dc/dt stands for the increased amount of permeated glucose amount versus time
(mg/min), V is the volume of the receiver chamber, A stands for the surface area of the
membrane, C0 is the initial glucose concentration in the donor compartment. (n=3)
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Figure 3.17. The curve of glucose concentration as a function of time.

Due to the avascular nature of the cornea, sustained nutrient transfer through any implant,
from the aqueous humor to the surface of cornea, is needed to maintain nutrition in the
stroma and epithelium. Glucose is essential for the aqueous humor, providing energy
metabolism to the cornea. For the ECC membrane, the variation of glucose concentration
with time is demonstrated in Figure 3.17. The calculated glucose permeability coefficient
of the ECC was approximately 2.1*10-6 cm/s, which is better than that of native cornea
(10-6 and 10-7 cm/s),[38] indicating that the ECC is competent for glucose diffusion when
implanted.

3.4 Conclusion
In this chapter, electro-compaction was applied to generate an ECC membrane with
aligned and condensed collagen fibrils for possible corneal tissue engineering. Compared
with NECC, this approach generated a more optimal biomimetic structure with enhanced
mechanical strength (10-fold increase in compressive and tensile modulus) and light
transmittance. The water content of the ECC membrane, however, was slightly lower than
that of NECC, likely due to the more compact and denser structure thereby reducing
hydration. The glucose permeability of ECC membrane showed a number that was higher
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than that of native human cornea. The Further work in this thesis will detail the application
of the ECC membrane on corneal regeneration.
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Chapter 4
In vitro characterization of human corneal
epithelial cell on electro-compacted collagen
membrane
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4.1 Introduction
Collagen, as the most abundant component of human cornea [1, 2], has been widely
explored in corneal bioengineering due to the tripeptide arginine-glycineaspartic acid
(RGD) recognition by the cell surface integrin receptors; being important for cell
adhesion, migration and proliferation [3]. For corneal epithelial application, collagen has
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demonstrated excellent biocompatibility with various kinds of corneal epithelial cells and
nerve growth in vitro [3-7], either directly applied as substrates to support corneal
regeneration and delivery or as coatings and supplementary to synthetic materials that are
mechanically stronger to improve the biocompatibility [8].

Figure 4.1. Schematic of corneal epithelial cell-seeded scaffolds for ocular surface
regeneration.

Fabricating collagen constructs that mimic the well-organized structure of native human
cornea and possess improved mechanical properties whilst maintaining biocompatibility
presents an ongoing challenge for tissue engineers[8]. Normally, crosslinked collagen
gel can be produced in a membrane form that is suitable as a growth substrate for corneal
cells [5]. For example, dehydrothermally crosslinked, EDC and glutaraldehyde
crosslinked gels are able to support the growth of human and rabbit corneal epithelial
cells (rCECs) [3, 5, 7, 9-11]. Composite collagen-chitosan membrane demonstrated
excellent mechanical toughness and optical properties and, when transplanted into a pig
cornea, allowed the regeneration of the epithelium and nerves in 12 months [12, 13]. Duan
et al reported that the incorporation of YIGSR (a model cell adhesion peptide) modified
dendrimer into collagen gel promoted the adhesion and proliferation of human corneal
epithelial cells (HCECs) as well as neurite extension from dorsal root ganglia [14].
Collagen vitrigel (CV), a collagen-based product with enhanced gel strength by
124

vitrification, has been shown to facilitate epithelial layer generation in vitro [15], and
exhibits sustained tissue transparency and low inflammatory response [16].

Electro-compacted aligned collagen fibres and membranes have already been
investigated in tendon,[17] cartilage,[18] nerve,[19] and vascular tissue engineering[20]
and demonstrated great potential. Most of these studies applied genipin for further
chemical crosslinking after compaction, which can achieve significantly enhanced
mechanical toughness but also induce strong autoﬂuorescence.[21] Moreover, genipin
crosslinking required long process time. Recently, ECC matrices were characterized in
vitro by seeding corneal keratocytes; with cell viability and proliferation well
maintained.[22] However, corneal epithelial recovery, which is the essential for ocular
surface health, has not been studied.

In this chapter, a comparison between ECC and NECC was conducted by seeding HCEC
on the top, followed by collaboratively assessing the cell viability and proliferation using
live/dead cells staining, PrestoBlue Assay and Ki67 nuclear proliferative marker staining.
The initial attachment was evaluated by quantifying the cell number after PBS washes,
and cell spread area was visualized by F-actin/DAPI staining and calculated using ImageJ,
in order to explore the advantage of ECC on corneal epithelial engineering compared
with NECC that has demonstrated superb biocompatibility both in vitro and in vivo [23].

4.2 Experimental section
4.2.1 Reagents and materials
Immortalized HCECs (SV40-Adeno vector transformed corneal cells) were procured
from RIKEN BioResource Centre Cell Bank. DMEM/F-12 (Dulbecco's Modified Eagle
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Medium/Nutrient

Mixture

F-12),

HEPES

(4-(2-hydroxyethyl)-1-

piperazineethanesulfonic acid) with high glucose (Life Technologies, Mulgrave,
Australia) , supplemented with 10% fetal bovine serum, Calcein AM/propidium iodide
(PI) (Life Technologies), Presto Blue™ (Life Technologies, Mulgrave, Australia), Triton
X-100 (Sigma-Aldrich, Australia), fluorescence conjugated antibodies KI67 (mouse,
1:200; Invitrogen), 4′,6-diamidino-2-phenylindole (DAPI, 10 μg/mL) (ThermoFisher
Scientific, Waltham, MA, USA), Alexa-488 phalloidin (ThermoFisher Scientific,
Waltham, MA, USA) were also obtained.

4.2.2 Cell culture of human corneal epithelial cells
The protocol was modified from previous publications [3, 10]. The cells were cultured in
DMEM/F-12, HEPES with high glucose, supplemented with 10% fetal bovine serum, 100
U P/S and 10 ng/ml human epidermal growth factor. HCECs were cultured in tissue
culture flasks in incubators (5% CO2 at 37 °C) with culture medium being changed every
other day. For testing on collagen membranes, cells were passaged onto ECC and NECC
membranes at a seeding density of 1 × 104 cells per cm2. Cell culture medium was
changed every 48 h post-seeding. HCECs were used between passages 30-40.

4.2.3 Live/Dead cell analysis
Calcein AM/propidium iodide (PI) staining was performed on HCECs cultured for 1, 3
and 5 days on ECC and NECC membranes. Briefly, cells were washed with PBS and
stained with calcein-AM (0.5mg/L) and PI (0.3mg/L) in PBS at 37 °C for 15mins to stain
live cells green and dead cells red, respectively. Confocal fluorescence microscopy was
performed using a Leica TSC SP5 II Confocal Microscope.
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4.2.4 Cell viability and metabolism
The cells in suspension were seeded at 1 × 104 cells/cm2 on ECC and NECC membranes.
After being incubated with PB reagent (10% in medium) for 0.5h at day 1, day 3 and day
5, the solutions were collected, and were then transferred into 96-well plates to measure
the fluorescence of the test reagent using a FLUO star Omega Microplate Reader with the
excitation/emission wavelengths set at 560/590 nm respectively.

4.2.5 Cell proliferation
HCECs seeded samples were fixed using a 3.7 % PFA solution in PBS at RT for 30 min,
and then washed and incubated overnight at 4 ºC with PBS containing 1%BSA and 0.3%
(v/v) Triton X-100 (Sigma). After that, samples were incubated with conjugated
antibodies KI67 (mouse, 1:200; Invitrogen) at 4 ºC overnight. Samples were then
counterstained using DAPI (10 μg/mL)at RT for 10 min. Samples were imaged with a
Leica TSC confocal microscope.

4.2.6 Cell attachment
HCECs were seeded at a density of 20000 cells/cm2 on ECC and NECC. Non-adherent
HCECs were removed by rinsing in PBS at 1, 2, 4 and 8 hours, post-seeding. PrestoBlue™ assay was performed to determine the cells remaining attached on the membranes.
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4.2.7 Cell spread area
Immunocytochemistry of filamentous actin was performed using Alexa-488 phalloidin.
Briefly, cells were washed with PBS, fixed with 3.7% paraformaldehyde in PBS for 10
mins and permeabilised with 0.1% Triton-X 100 in PBS for 5 mins at RT. Following a
PBS wash, samples were labelled with Alexa 488-Phalloidin for 40 mins at RT in the
dark. Nuclei were counterstained using DAPI (10 μg/mL). Samples were observed using
a Leica TSC confocal microscope. The spread area of 20 cells for each sample was
measured using ImageJ and the mean and the standard deviation were calculated.

4.2.8 Statistics
Experimental data were analyzed statistically using analyses of variance. The values of
probability (p-value) were calculated. P-values less than 0.05 were considered to be
significant (*P≤0.05, **P≤0.01). IBM SPSS statistics 25 was used for all analysis.

4.3 Results and discussion
4.3.1 Live/Dead cell analysis
Cytocompatibility is a critical assessment if materials are to be used as bioengineered
scaffolds. Here the cytocompatibility of HCECs was investigated using Live/Dead cells
staining. HCECs were seeded on ECC and NECC membranes and allowed to grow for 5
days with culture medium changed every other day until confluence. Fluorescence images
of cells treated with calcein AM (stains surviving cells green) and PI (stains dead cells
red) at day 1, day 3 and day 5 were captured using a confocal microscope and are
presented in Figure 4.3. The staining shows that green fluorescence was predominant on
both ECC and NECC with only a few cells that are undergoing apoptosis and necrosis,
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which indicates a favourable cell viability of HCECs. A healthy and continuous
epithelium is essential for clear vision [24], with corneal epithelial cells regenerating
every 7–10 days [25]. Here, HCECs proliferated and achieved confluence at day 5 on both
ECC and NECC membranes (Figure 4.3), suggesting a qualified substrate for HCECs
growth.

Figure 4.2. Optical microscopy of HCECs on ECC and NECC at day 1, day 3 and day 5.
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Figure 4.3. Time course of live (Calcium AM) and dead (propidium; PI) of HCECs on
ECC and NECC membranes.

4.3.2 Cell viability and metabolism
The total cell metabolic activity was characterized by presto-blue assay, a further
indication of cell proliferation. In accord with the staining images, a growing trend was
observed from day 1 to day 5. Moreover, at day 1, the fluorescence reading of ECC was
slightly higher than that of NECC. Conversely, at day 3 and day 5, no significant
difference was observed (P>0.05) (Figure 4.4).
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Figure 4.4. Total metabolic activity as an indicator of viability and proliferation of HCECs
measured by Presto-blue. Error bars: +/-SD. No significant differences observed at all
time points (P>0.05).

4.3.3 Cell proliferation
Immunohistochemical staining of proliferating cells with the nuclear proliferation marker
Ki67 antibodies has widely been applied in assessing cell proliferation [26-28]. Here,
immunophenotyping at 5 days post-seeding demonstrated that HCECs expressed Ki67
(Figure 4.5) on both ECC and NECC. NECC has already demonstrated excellent
biocompatibility on corneal epithelial cells in vitro and for epithelium regeneration in
clinical follow-up [3] [23]. Our in vitro characterization of HCEC culture on ECC and
NECC membranes demonstrated comparable biocompatibility with live and dead cell
staining showing high cell viability on both membranes. This was consistent with Ki67
labelling of the growth fraction of a given cell population, and the Presto-BlueTM assay
for metabolic activity, which is indicative of both cell survival and proliferation.
Therefore, HCEC survival, growth and activity were similar on ECC and NECC
membranes and therefore were not hindered by ECC compared with NECC.
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Figure 4.5. Immunolabelling of cellular marker for HCECs proliferation Ki67 at day 5.
(Scale bar: 300 µm).

4.3.4 Cell attachment
Cell attachment or adhesion is critical for cell growth and migration on a supporting
substrate for tissue engineering such as cornea[29]. Previous studies have reported that
the adhesion of corneal epithelial cells can be improved by various techniques, such as
collagen coating [30], RGD modification [31] and topographical modification [32].
Presto-blue reading of cell-seeded membranes after PBS wash showed that the cell
numbers remaining on ECC were significantly higher than that of NECC at 1h, 2h, 4h
(P<0.01) while no significant difference observed at 8h (Figure 4.6), indicating a faster
initial attachment on ECC.
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Figure 4.6. Presto-BlueTM-based analysis after PBS rinse of HCECs. Significant
differences were observed between the two groups at 1h, 2h and 4h (** P<0.01).

4.3.5 Cell spread area
Normally, after initial attachment, cells tend to grow and migrate across a substrate,
underpinned by increased contact area and adhesion strength per cell, culminating in
increased substrate utilization and log-phase population growth before reaching
confluence [33] (Figure 4.7).

Figure 4.7. The stages of cell adhesion include attachment, spreading, and strong/focal
adhesions with the adhesive strength increasing from left to right.
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Time course analysis of PBS-washed HCECs on ECC and NECC membranes using F-actin
labelling (Figure 4.9) and Presto-BlueTM (Figure 4.10) demonstrated greater cell spread
and attachment on ECC membrane compared with NECC membrane. More specifically,
for ECC membrane, unlike NECC membrane, spreading cells with increased contact area
or obvious elongation (higher aspect ratio) were observed at 2h. At 4h, cell attachment and
spreading on ECC membrane was seemingly more evident with cells visibly becoming
integrated with the substrate. However, by 8h culture there were no differences of cell
number but those on the ECC membrane still exhibited a larger spread area (Figure 4.9).
The bright field images showed a consistent result with apparent integration with the
substrate on ECC at 4h (Figure 4.8), while cells on NECC appeared to have a third
dimension. The higher aspect ratio observed for cells on ECC potentially relates to surface
topography and/or modulus, with more compact and greater alignment of collagen fibrils
conducive to cell spreading, increased adhesion, and flattened morphology. Several earlier
reports highlighted the importance of nanoscale topography and stiffness for optimal cellsubstratum interaction and cellular adhesion [34-36]; not least of all for corneal
regeneration [37]. Corneal epithelial reconstruction by rapid engraftment is important for
corneal bioengineering, with optimal preparation of host corneal surface an essential
prerequisite for stable attachment of implanted corneal epithelial tissue and cells [23]. As
such, the ECC membrane would appear to be superior to the NECC membrane for corneal
epithelial cell support and tissue regeneration.
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Figure 4.8. Optical microscopy of HCECs on ECC and NECC after PBS washes at 1h,
2h, 4h and 8h (red arrow: elongated cells).

Figure 4.9. F-actin staining of HCECs (Scale bar: 300 µm and 150 um) on ECC and
NECC membranes.
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Figure 4.10. Cell spread area of HCECs on ECC and NECC membranes. Significant
differences (P<0.01) were observed between ECC and NECC at 2h, 4h and 8h.

4.4 Conclusion
In this chapter, we explored the potential of utilizing ECC on corneal epithelial
bioengineering by comparing HCECs behaviours on ECC and NECC. The results
demonstrate that HCECs were able to achieve confluence on ECC with similar
proliferation rate to those on NECC. The proliferative ability of HCECs on ECC was well
maintained according to the obvious expression of Ki67. Interestingly, the cell attachment
of HCECs was significantly improved on ECC with faster attachment, larger spread area
and higher aspect ratio.

In the first two chapters, electro-compaction was applied to fabricate ECC membrane for
corneal epithelial engineering. Compared with NECC, ECC demonstrated a more optimal
biomimetic structure with enhanced mechanical strength, favourable light transmittance
and glucose permeability. The ability to support the growth and promote the attachment
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of HCECs identifies ECC to be a superior candidate that facilitates corneal epithelial cell
attachment.
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Chapter 5
Constructing multilayered corneal stromal model
using electro-compacted collagen membranes
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5.1 Introduction
During the past decade, advances in tissue engineering have provided opportunities for
corneal regeneration by applying principles of materials engineering and life sciences [1].
Although materials and techniques for corneal epithelial and endothelial bioengineering
have been widely reported, more difficult construction of a biomimetic stromal model is
yet to be realised [2]. Corneal stroma is the primary component of the cornea, accounting
for 80%~85% of the entire cornea [3]. Structurally, the stroma is composed of layers of
parallel collagen fibrils forming 250-300 flattened lamellae. Lamellae are arranged
orthogonally and typically filled with corneal keratocytes (Figure 5.1). This highly
organized structure contributes to the transparency and mechanical strength of cornea,
and is therefore key to engineering cornea in vitro [3].

Figure 5.1. (Left) Schema of human cornea (five layers from top to bottom); (Right)
native human corneal stroma consists of orthogonally arranged collagen fibrils.
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Stroma bioengineering has included cell-free (e.g., decellularized cornea [4], collagen
[5], silk fibroin [6]) and cell-laden (e.g., HCFs (human corneal fibroblasts)-encapsulated
collagen gel[7], HCFs-contained silk fibroin-based structure[8], HCFs-encapsulated
fibrin/agarose gel[9] matrices. While several approaches recapitulated many of the
properties of human cornea [7, 8], most failed to provide biomimetic structure. More
recently, stroma-mimetic scaffolds have been generated by assembling electro-spun
synthetic polymer nanowires (Figure 5.2) [10], stacking patterned silk membranes [11,
12], and forming collagen gel composed of aligned fibres in a magnet (Figure 5.3) [13].
However, electro-spun synthetic polymer and stacked silk scaffolds only used collagen
as a coating or additive to improve the biocompatibility rather than as the main component
and supportive structure [10, 11]. The magnetic technique enables fabrication of scaffolds
with similar structure to human cornea stroma, but requires covalent crosslinking to
enhance the mechanical property [13]. Moreover, the transparency and graft retention
need to be improved through incorporation of proteoglycans and optimization of
crosslinking [13, 14]. More recently, co-culture systems of corneal stromal cells and other
cells (dorsal root ganglion neurons [15] and corneal epithelial [16]) were well developed,
facilitating the construction of multilayered and full-thickness functional corneal
substitute.
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Figure 5.2. Schematic drawing of the fabrication of aligned portable nanofibre meshes
and the organized multi‐nanofibre mesh cellular constructs. (A) Representative scanning
electron microscopy image of aligned electrospun nanofibres, scale bar = 15 μm; (B)
cellulose acetate frames are adhered to the aligned nanofibres and a scalpel is used to
sever the frames from the collecting frame; (C) the portable fibre meshes are seeded with
cells and arranged orthogonally using a layer‐by‐layer method with acetate and filter
paper spacers between the layers; (D) cells are allowed to attach for 2‐3 hrs before
collagen solution is allowed to infiltrate the fibres, securing the fibres within the construct;
(E) the excess fibres and acetate frames are removed, forming nanofibre‐cellular
constructs. (Reprinted with permission from ref [10]).
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Figure 5.3. (A–E) optical micrographs using a polarizing microscope descending
vertically through a ≈2 mg/ml gel consisting of three (each ≈0.5 mm thick) lamellae
supported on a glass-bottomed culture dish. Images show successive switches in
orientation; the middle layer is perpendicular to the other two; (F) optical micrograph of
an initially similar (concentration and thickness) three lamellae scaffold seen in crosssection perpendicular to the lamellae surface (thickness=38 μm). The gel was fixed,
dehydrated, embedded and stained with Azur II-Methylene blue. The middle layer is
perpendicular to the other two. (Reprinted with permission from ref [13]).

Here we describe the construction of a biomimetic corneal stroma model using electrocompacted collagen and primary hCSCs (human corneal stromal cells). Electrocompacted collagen fibres and membranes have been described for various applications,
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including tendon repair [17], neuronal [18] and skin regeneration [19]. For corneal
bioengineering, EDC/NHS crosslinked EC fibres have previously been shown to support
the growth of keratocytes [20] and our own studies have also demonstrated that EC
membranes can enhance the attachment of human corneal epithelial cells compared to
conventional collagen gel. However, the previous study merely assessed the cell viability
and proliferation of primary corneal keratocytes on the surface of EC membranes. The
key point of this study was to develop a biomimetic 3D corneal stroma model from EC
membranes comprising aligned collagen fibrils and corneal stromal cells. Constructs
displayed native-like collagen structure, suitable light transmittance, glucose permeability
and biodegradability. hCSCs cultured on EC membranes as well as between stacks of
sequentially assembled membranes showed normal morphology and high viability in a
quiescent state, with transcriptional analyses indicative of upregulated keratocyte marker
(ALDH3) and downregulated fibroblast markers (α-SMA and Thy-1). Together, these
results support the use of layered hCSC-EC for a CSM, which could be useful for cornea
stroma research and regeneration.

5.2 Experimental section
5.2.1 Reagents and materials
Type I bovine collagen (Advanced BioMatrix), PBS tablet (Sigma, Australia), PDMS
(MOMENTIVETM), Photo-initiator (MOMENTIVETM), nylon membrane filters
(Whatman), DMEM/F 12 no red (Life Technologies, Australia), Fetal Bovine Serum
(Interpath), Insulin-Transferrin-Selenium-X Supplement (100X) (Life Technologies,
Australia), PrestoBlue™(Invitrogen, Australia), Ki67 antibody (mouse), (Invitrogen),
Triton-100 (Sigma, Australia), Albumin bovine serum

(Sigma, Australia),

Paraformaldehyde (Fluka), D-glucose (Sigma, Australia), 4, 6-diamidino-2-phenylindole
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(DAPI) (Invitrogen), Glucose assay kit (Sigma, Australia), Basic fibroblast growth
factor (bFGF) (Life Technologies, Australia), Penicillin/Streptomycin (Gibco) were
obtained.

5.2.2 Fabrication of (CSM) corneal stromal model
5.2.2.1 Electro-compaction of collagen membrane
The method for the electro-compaction of collagen was modified from previously
published reports [21, 22]. Acid soluble monomeric collagen solution from bovine hides
(Advanced Biomatrix, San Diego, CA, catalogue # 5010-D) was dialyzed against
ultrapure water (18.2 MU-cm) at 4°C for 48h to remove salts. The resultant collagen
solution was loaded into the electro-compaction cell (Figure 5.4B) that comprised a
stainless-steel plate as cathode and ITO glass plate as anode. Silicone rubber rims (15mm
in diameter and 2mm in thickness) were printed using a 3D-Bioplotter System (Envision
TEC) and applied as spacers. Nylon rims (9mm in diameter) were cut from nylon
membrane filters (Whatman LOT: D112754) using a laser engraver (Universal Laser
Systems) and loaded into the cell as collectors for EC membranes. Applying 5V for 300s,
the collagen solution separated into a lower collagen membrane and an upper aqueous
phase. The upper aqueous phase was then replaced with PBS and incubated at room
temperature (RT) for 18h before the membrane was collected.
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Figure 5.4. Photos of laser-cut nylon rims (left) and electro-compaction device (right).

5.2.3.2 Measuring the thickness of EC membranes
The thickness of each EC membrane was measured using an Atomic Force Microscope
(Park Systems XE-Bio) after the surface water was gently blotted off. Experiments were
performed at room temperature using silicon probes (BRUKER, DNP-S10). Membrane
thicknesses were measured at the edge of the samples [21].

5.2.2.3 Preparation of conventional collagen gel
Conventional collagen (CC) gels were dehydrothermally prepared. Briefly, the collagen
solution was mixed with 10x PBS with the pH adjusted to 7.0–7.5. The solution was then
gelated by incubating at 37 °C for 2 hr.

5.2.2.4 Isolation and culture of primary human corneal stromal cells (hCSCs).
Human corneal tissue obtained from the NSW tissue bank was used for hCSC isolation,
as approved by the Human Research Ethics Committee of NSW South Eastern Sydney
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Local Health District (HREC ref no: 15/251) and the Human Research Ethics Committee
of University of Wollongong/Illawarra Shoalhaven Local Health District (HE15/483).
Briefly, the epithelium, Descemet's membrane and endothelium were sequentially
removed, and the stroma was cut into ~1 cm3 pieces. The pieces were cultured in petri
dishes (35mm, Thermo Fisher Scientific, USA). DMEM/F12 with 5% FBS were then
dropped onto the surface of the stromal explants, followed by a 15min-incubation at room
temperature in the biological safety cabinet and then transferred into incubators for 2h.
Explants were then incubated in DMEM/F12 with 5% FBS overnight and floating
explants were removed. Stromal cells growth from the explants were observed after 2-3
days incubation. Culture medium was changed every 2 days and cells were passaged upon
reaching 70%-80% confluence and cryo-preserved at -80 oC for future use. Cells were
expanded in DMEM/F12 with 10% FBS and 1% penicillin/streptomycin. As described
previously [10, 23], cells were stabilized in serum-free medium (SFM) (DMEM/F12 1:1,
1% (v/v) 100x Insulin-Transferrin-Selenium (ITS), 0.01% (v/v) 10M phosphoascorbic
acid and 0.01% (v/v) 100 ng/nL FGF-2) for 3 days before further use. All cell-based
experiments were performed with passage 3~4 hCSCs.

5.2.2.5 Fabrication of CSM
hCSCs were seeded at 2.5 x 104 cells/cm2 on EC membranes and incubated for 12 hr to
allow cell adhesion. hCSCs-seeded membranes were then successively stacked, one on
top of another with collagen fibrils of each layer orthogonally arranged and CSMs were
weighed down by sterilized acrylic rims to allow complete integration of EC membranes.
The constructs were incubated in SFM and the medium was changed every two days.
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Figure 5.5. Schematics of the human cornea and fabrication of EC membranes and
biomimetic multilayered corneal stromal models (CSMs). (A-B) Schema of electrocompaction to form collagen membranes that are then collected within filter membrane
rims. (C-D) Schema of seeding EC membranes with hCSCs that are assembled
orthogonally, layer-by-layer, to construct 3D CSMs.

Figure 5.6. Photo of laser-cut acrylic rims.

5.2.3 Scanning Electron Microscope (SEM)
Scanning Electron Microscopy (SEM) was performed using a JSM-7500FA LV Scanning
Electron Microscope, operating at 10 kV. Samples were fixed using 2.5% glutaraldehyde
in PBS at 4 °C for 2 hr, followed by three PBS washes (1 min each). Samples were then
dehydrated through a series of ethanol solutions (1 x 10 min in 30%, 50%, 75%, 90%,
followed by 2 x 10 min in 100%) and then critical-point dried with a Leica CPD030
151

Critical Pt Dryer. Samples were mounted on the specimen holder and sputter coated with
10 nm gold using a Dynavac Sputter Coater, followed by observation. For cross-sectional
imaging, samples were halved using a blade and mounted on a 90 degree angled specimen
holder before sputter coating.

5.2.4 Rheological test
Rheology was performed using a TA AR-G2 rheometer at RT with a 12 mm diameter
parallel plate. An initial strain sweep test was performed to determine the linear
viscoelastic (LVE) range, where G’ (elastic modulus) and G” (viscous modulus) were
independent of the strain amplitude. The oscillatory measurements were then performed
at strain 1% in the frequency range 0.01-100 HZ.

5.2.5 Biodegradation
CSMs were incubated in SFM that was replaced every 2 days and the dehydrated weights
were recorded at days 1, 7 and 14 (n = 6). The average and variance of the dry weight of
all samples were calculated. The residual mass% was calculated according to the
following equation: Residual mass% = dehydrated mass / initial dehydrated mass.

5.2.6 Transmittance test
The transparency was evaluated by measuring total transmittance in the visible light
region using a ColourQuest XE (HunterLab, USA) spectrophotometer. The
standardization was conducted according to the following steps. Firstly, the black card
was placed flat against the transmission port (hole in the sphere). The black card device
was then removed from the transmission compartment followed by placing the blank at
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the transmission port for the white tile at the reflectance port. The whole process was
performed with the transmission compartment door fully closed. After the instrument
flashed, the standardization was completed and the blank could be removed from the
transmission compartment. The CIE L*a*b* (CIELAB) system was used to describe the
values, where the value L (luminosity) represented the level of light or dark ranging from
white (L = 100) to dark (L = 0)[24].

5.2.7 Glucose permeability test
Diffusion permeability study was carried out using two-compartment diffusion chambers
with mechanical stirring at 100 rpm at room temperature, according to the previously
published protocols [25, 26]. CSM was mounted between the two chambers (permeate
chamber and receptor chamber) without leaking. The permeate chamber was filled with
glucose solution (10mg/ml) and the receptor chamber was sampled every 5minutes. The
samples were then assessed by spectrophotometry at 540 nm using a glucose assay kit
(GAGO-20; Sigma-Aldrich) with a UV-3600 spectrophotometer (Shimadzu).

5.2.8 hCSCs proliferation analysis
PrestoBlue (Invitrogen) assay was performed for cell proliferation analysis. CSMs were
incubated with 10% PrestoBlue reagent (v/v) in culture medium for 30 min at day 1, 3, 5,
7 and 14 day. The media were collected and transferred into 96-well plates to measure
the fluorescence of the test reagent using a FLUO star Omega Microplate Reader with the
excitation/emission wavelengths set at 560/590 nm for Presto-Blue.
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5.2.9 Immunocytochemistry
Samples were washed with PBS and then fixed in 3.7 % PFA solution in PBS at RT for
30 min. Following 3 times (5mins each) PBS washes, samples were incubated overnight
at 4 ºC with PBS containing 1%BSA and 0.3% (v/v) Triton X-100 (Sigma). After that,
samples were incubated with conjugated antibodies KI67 (mouse, 1:200; Invitrogen) at 4
ºC overnight. Samples were then counterstained using DAPI (10 μg/mL)at RT for 10 min.
Samples were imaged with a Leica TSC confocal microscope.
For F-actin staining, samples were permeabilised with 0.1% Triton X-100 for 10 min after
fixation and then stained with Alexa 488-Phalloidin (ThermoFisher Scientific, Waltham,
MA, USA) in 1% BSA for 40 min at RT in the dark and the nuclei were visualized using
DAPI before observation. The morphology of the cells on the substrate was analysed with
ImageJ. The angle between the long axis of the cell and the direction of aligned collagen
fibrils was defined as the orientation angle [27, 28]. An angle of 360° corresponds to
complete orientation. The larger the angle, the more the cell is oriented with the feature
direction.

5.2.10 Statistical analysis
Experimental data were analyzed statistically using ANOVA with Tukey post hoc test.
Homogeneity of variance tests were performed to confirm that the statistical assumptions
were met for ANOVA. P-values less than 0.05 were considered to be significant (*P≤0.05,
**P≤0.01, ***P ≤ 0.001). IBM SPSS statistics 25 was used for all analyses.
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5.3 Results and Discussion
5.3.1 Culture of primary human corneal stromal cells (hCSCs)
The maintenance of hCSCs with a specialised keratocyte phenotype is an essential
requirement for modelling corneal stroma. The ability to transform the keratocytes into
proliferating fibroblasts is necessary, however, for tissue engineering. Therefore, for in
vitro cell expansion prior to culturing on EC films, we cultured hCSCs in serumcontaining media to induce fibroblasts that are proliferative, followed by stabilisation in
serum-free media (SFM) with supplements to restore a dormant keratocyte phenotype
[29]. hCSCs were stabilized for 3 days in SFM before seeding onto EC films and ongoing
culture in SFM [23]. As expected, decreased staining of the nuclear proliferation marker
Ki67 was detected for cells cultured in SFM, while constant and strong Ki67 staining was
detected for cells cultured in FBS media (Figure 5.8). Similarly, PrestoBlue-based
analysis demonstrated higher cell proliferation of hCSCs in FBS compared to SFM
(Figure 5.9). Although hCSCs in SFM exhibited a flattened fibroblastic morphology,
this is consistent with a previous report of non-proliferating corneal fibroblasts showing
decreased Ki67 staining when cultured in DMEM/ITS medium up to 7 days [30].
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Figure 5.7. Optical images of hCSCs cultured in FBS and SFM at day1, day2 and day3.
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Figure 5.8. Ki67/DAPI staining of hCSCs in serum-contained (FBS) and serum-free
(SFM) media at day 1, day 2 and day 3.

Figure 5.9. Prestoblue reading of hCSCs in FBS and SFMat day 1, day 2 and day 3.

5.3.2 Fabrication of EC membrane
The thicknesses of EC membranes with varied collagen concentrations were measured
using AFM (Figure 5.10). Since the thickness of native human cornea is 400-600 μm
[31], 0.25 mg/ml collagen was selected to prepare EC membranes (144.43 ± 52.05 μm)
for the construction of CSMs. The rate of electro-compaction to form the membrane can
be adjusted by changing the applied voltage according to this author’s previous and other
published reports [21]. This resulted in more rapid membrane formation compared to
previously published reports [17, 32, 33]. However, the current density was also large
compared with the potentials required for HER (hydrogen evolution reaction), oxygen
reduction and oxygen evolution [32]. Importantly, high current densities can lead to
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bubble generation on a cathode due to H2 and O2 formation, impairing the integrity of
generated collagen membranes (Figure 5.11). On the other hand, insufficient current
density results in incomplete compaction (Figure 5.11).

Figure 5.10. Thickness of EC membranes fabricated using collagen with varied
concentrations.

Figure 5.11. Current response (i-t curve) of electro-compaction of collagen.
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To promote fibrillogenesis and mechanical toughness, EC membranes were incubated in
PBS for 18 hr post-electrocompaction. The membranes were then mechanically sufficient
to be handled with filter membrane rim by tweezers and the toughness and flexibility
were evaluated by repeatably pricking the sample using the tip (Figure 5.12).

Figure 5.12. Consecutive photos (A to D) of EC membrane when pricked by tweezers.
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Figure 5.13. Photo of CSM when handled by tweezer.

5.3.3 Rheological test

Figure 5.14. Strain sweep test was carried out to determine the linear viscoelastic (LVE)
range.
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Figure 5.15. Elastic modulus (filled symbols) and viscous modulus (open symbols) versus
frequency for collagen samples before and after electro-compaction, with and without
PBS treatment.
An initial strain sweep test was performed to determine the linear viscoelastic (LVE)
range, where G’ (elastic modulus) and G” (viscous modulus) were independent of the
strain amplitude （Figure5.14）. Then, rheological testing was carried out to confirm
the effect of electro-compaction and PBS incubation. G’ (storage modulus) and G”
(viscous modulus) vs. frequency for non-electrocompacted collagen (NECC),
electrocompacted collagen before (ECCB) and after (ECCA) PBS treatment is given in
Figure 5.15. The G’ of all samples was continually higher than G” in the frequency range,
with G’ weakly dependent on frequency, which indicates that the elastic behaviour
dominates the viscous behaviour. The G’ of ECCB was significantly higher (5-fold) than
that of NECC, confirming successful compaction of collagen. Compared with ECCB, a
slight increase (20%~50% depending on frequency) of G’ was observed on ECCA, which
was in accordance with a previous report of mechanical enhancement of electrocompacted collagen after PBS treatment [34].
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5.3.4 Effect of collagen orientation on cell morphology

Figure 5.16. SEM images of EC collagen membrane and CSM. (A-B) SEM micrographs
of the surface of CSMs, showing alignment of collagen fibrils in the direction of the arrow.
(C-D) SEM micrographs of cross-sections of CSMs.

Figure 5.17. SEM images of EC collagen and conventional collagen.
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Figure 5.18. Effect of collagen fibril alignment on immunolabelled cell orientation, with
fibril alignment indicated by the arrow. (A) F-actin labelling of hCSCs on EC and CC
revealed cell orientation was influenced by the alignment of collagen fibrils (scale bar:
300 μm). (B) SEM micrographs of the surface topographies of EC and CC respectively,
with collagen fibrils of EC aligned with the direction of current (arrow) employed for
electro-compaction, while those of CC were disordered.

Assessment of EC membranes by SEM demonstrated highly-condensed and aligned
collagen fibrils running parallel to the direction of current through the electro-compaction
chamber (arrow) (Figure 5.16 A and B). In contrast, collagen fibrils of CC (conventional
collagen) membranes were disordered. The calculated orientation angles of hCSCs on EC
(332°±25°) was significantly higher (n=180, P<0.05) than those on CC (308°±35°),
indicating the orientation of hCSCs was directed by the aligned collagen fibrils of EC.
Moreover, EC exhibited smaller fibrils (30~50 nm diameter) compared to CC (100~150
nm diameter) (Figure 5.17), with the former being similar to that of native human cornea
(31~34 nm) [35]. A variety of publications have reported the fabrications and bioapplication of 2D EC collagen membranes [21, 22, 32, 36, 37]. None of these studies,
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however, revealed the correlation between the direction of collagen alignment and the
current.

When developing substrates for corneal bioengineering, topographical cues are important
and able to profoundly affect cell behaviours. For instance, the attachment and
proliferation of human corneal epithelial cells can be promoted by parallel line-patterned
surfaces [38, 39] and the depth and width of grooves influence cell orientation of human
corneal fibroblast [40]. For stromal engineering, aligned fibres can induce keratocyte-like
morphology and phenotype [10]. Various techniques have been applied to create
topographies that direct the orientation and phenotypic state of corneal stromal cells,
including soft lithography [40], electro-spinning [10], and direct-write assembly [41].
Most reports, however, describe surfaces presented in micron rather than nano dimension,
and usually applied collagen merely as an additive for improving biocompatibility. To
investigate whether the orientation of hCSCs is affected by aligned collagen fibrils, Factin staining was employed to visualise cells cultured for 12 hr on EC and CC
membranes. The collagen fibrils of EC membranes appeared to influence hCSC
orientation, with cells clearly aligned with collagen fibrils (Figure 5.18A). In contrast,
hCSCs on CC membranes were patently disordered (Figure 5.18A), consistent with the
underlying substrate topography (Figure 5.18B).
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5.3.5 Biodegradation

Figure 5.19. Digital images of CSMs cultured in SFM up to 14 days.
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Figure 5.20. In vitro biodegradability test of CSMs cultured in SFM up to 14 days.
The integrity of all CSMs were well maintained in SFM up to day 14 with no apparent
degradation or contraction observed as evident by digital photography (Figure 5.19).
CSM appeared to be highly transparent with the characters underneath clearly seen and
no opaqueness detected during the whole process. A slight decrease in dehydrated mass,
however, was observed at day 7 and day 14. At day 14, appropriately 80% of the initial
mass remained (Figure 5.20). Optimum biodegradation and tissue regeneration rates are
important for the clinical application of bioengineered corneal stroma. Twenty percent
weight loss over 14 days may be acceptable according to previous studies on the secretion
of corneal stromal tissue and matrix using corneal stromal cells (3 weeks [42], 9 weeks
[12]). However, it will be important to perform in vivo testing for full optimization of the
construction of CSMs in the future.
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5.3.6 Transmittance test

Figure 5.21. L* value of CSMs with and without hCSCs cultured in SFM at day 1, day 7
and day 14.

168

169

Figure 5.22. Total transmittance of CSMs with and without hCSCs at day 1, day7 and
day 14.

As the transparent anterior part of the eye, the cornea is critical role for maintaining
normal vision. Therefore, transparency of CSMs and consequently component
biomaterials is essential to recapitulate native tissue function, albeit also important for
observing constituent cell behaviour [43]. Presently, CSMs remained highly transparent
for the duration of study and the integrity of all CSMs was well maintained, with no
apparent degradation or contraction (Figure 5.19).

L* (luminosity) of CSMs was evaluated using a ColourQuest XE spectrophotometer.
While the L* was retained for all samples tested with or without cells (P>0.05),
predictably the presence of hCSCs marginally impaired light transmission (P<0.05,
87~89% vs 81~83% respectively) (Figure 5.21). Moreover, cell-free samples displayed
constant higher total transmittance compared with cell-contained samples at 400~700
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wavelength (Figure 5.22). Interestingly, wounding of native cornea is characterised by
quiescent corneal keratocytes becoming activated and transforming into mitotically active
fibroblasts/myofibroblasts that express fibrotic extracellular matrix, culminating in scar
deposition and tissue opaqueness [44]. As such, maintenance of clear constructs is
consistent with the hCSCs in CSMs being in a quiescent state; discussed further in
Chapter 6.

5.3.7 Glucose permeability test

Figure 5.23. Glucose permeability of CSMs cultured in SFM at day 1, day 7 and day 14.
The avascular nature of natural cornea determines the importance of favourable scaffold
permeability which facilitates nutrient diffusion from the aqueous humor to the cornea
surface [26]. Similarly, CSM permeability is critical for the wellbeing of constituent
stromal cells enabling, for example, effective diffusion of glucose to provide sufficient
energy for corneal metabolism [45]. The glucose permeability coefficient of CSMs was
tested and monitored up to day 14 (Figure 5.23), demonstrating greater permeability than
that of native human cornea (10-6-10-7 cm/s) [46]. Remarkably, a small increase in
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permeability over time was indicated, which was consistent with the above described
small but measurable reduction in mass.

5.4 Conclusion
In this chapter, a novel robust 3D biomimetic corneal stromal model has been prepared
using electro-compacted collagen membranes and primary hCSCs. The fabrication
process involved no addition of any other materials and toxic reagents. The aligned
collagen fibrils of the membranes acted as a guidance for cell orientation and elongation,
eliminating the need for topographical or other modification. The light transmittance,
glucose permeability and biodegradability verify the potential of the models as substitutes
for human corneal stroma.

5.5 References
1.

Ghezzi, C.E., J. Rnjak-Kovacina, and D.L. Kaplan, Corneal tissue engineering:
recent advances and future perspectives. Tissue Engineering Part B: Reviews,
2015. 21(3): p. 278-287.

2.

Chen, Z., et al., Biomaterials for corneal bioengineering. Biomedical Materials,
2018. 13(3): p. 032002.

3.

DelMonte, D.W. and T. Kim, Anatomy and physiology of the cornea. Journal of
Cataract & Refractive Surgery, 2011. 37(3): p. 588-598.

4.

Márquez, S.P., et al., Decellularization of bovine corneas for tissue engineering
applications. Acta biomaterialia, 2009. 5(6): p. 1839-1847.

5.

Crabb, R.A. and A. Hubel, Influence of matrix processing on the optical and
biomechanical properties of a corneal stroma equivalent. Tissue Engineering Part
A, 2008. 14(1): p. 173-182.

6.

Lawrence, B.D., et al., Silk film biomaterials for cornea tissue engineering.
Biomaterials, 2009. 30(7): p. 1299-1308.

7.

Germain, L., et al., Reconstructed human cornea produced in vitro by tissue
172

engineering. Pathobiology, 1999. 67(3): p. 140-147.
8.

Gil, E.S., et al., Helicoidal multi-lamellar features of RGD-functionalized silk
biomaterials for corneal tissue engineering. Biomaterials, 2010. 31(34): p. 89538963.

9.

de la Cruz Cardona, J., et al., Transparency in a fibrin and fibrin–agarose corneal
stroma substitute generated by tissue engineering. Cornea, 2011. 30(12): p. 14281435.

10.

Wilson, S.L., et al., Chemical and topographical effects on cell differentiation and
matrix elasticity in a corneal stromal layer model. Advanced Functional Materials,
2012. 22(17): p. 3641-3649.

11.

Wang, S., et al., In vitro 3D corneal tissue model with epithelium, stroma, and
innervation. Biomaterials, 2017. 112: p. 1-9.

12.

Ghezzi, C.E., et al., 3D functional corneal stromal tissue equivalent based on
corneal stromal stem cells and multi-layered silk film architecture. PloS one, 2017.
12(1): p. e0169504.

13.

Torbet, J., et al., Orthogonal scaffold of magnetically aligned collagen lamellae
for corneal stroma reconstruction. Biomaterials, 2007. 28(29): p. 4268-4276.

14.

Builles, N., et al., Use of magnetically oriented orthogonal collagen scaffolds for
hemi-corneal reconstruction and regeneration. Biomaterials, 2010. 31(32): p.
8313-8322.

15.

Wang, S., et al., Coculture of dorsal root ganglion neurons and differentiated
human corneal stromal stem cells on silk‐based scaffolds. Journal of Biomedical
Materials Research Part A, 2015. 103(10): p. 3339-3348.

16.

Gosselin, E.A., et al., Multi‐layered silk film coculture system for human corneal
epithelial and stromal stem cells. Journal of tissue engineering and regenerative
medicine, 2018. 12(1): p. 285-295.

17.

Cheng, X., et al., An electrochemical fabrication process for the assembly of
anisotropically oriented collagen bundles. Biomaterials, 2008. 29(22): p. 32783288.

18.

Abu-Rub, M.T., et al., Nano-textured self-assembled aligned collagen hydrogels
promote directional neurite guidance and overcome inhibition by myelin
associated glycoprotein. Soft Matter, 2011. 7(6): p. 2770-2781.

19.

Kang, L., et al., Fabrication and In Vitro Characterization of Electrochemically
Compacted Collagen/Sulfated Xylorhamnoglycuronan Matrix for Wound Healing
173

Applications. Polymers, 2018. 10(4): p. 415.
20.

Kishore, V., et al., In vitro characterization of electrochemically compacted
collagen matrices for corneal applications. Biomedical Materials, 2016. 11(5): p.
055008.

21.

Kumar, M.R., E.F. Merschrod S, and K.M. Poduska, Correlating mechanical
properties with aggregation processes in electrochemically fabricated collagen
membranes. Biomacromolecules, 2009. 10(7): p. 1970-1975.

22.

Younesi, M., et al., Fabrication of compositionally and topographically complex
robust tissue forms by 3D-electrochemical compaction of collagen. Biofabrication,
2015. 7(3): p. 035001.

23.

Isaacson, A., S. Swioklo, and C.J. Connon, 3D bioprinting of a corneal stroma
equivalent. Experimental eye research, 2018. 173: p. 188-193.

24.

Menegassi, B., A.M. Pilosof, and J.A. Arêas, Comparison of properties of native
and extruded amaranth (Amaranthus cruentus L.–BRS Alegria) flour. LWT-Food
Science and Technology, 2011. 44(9): p. 1915-1921.

25.

Richter, T. and S. Keipert, In vitro permeation studies comparing bovine nasal
mucosa, porcine cornea and artificial membrane: androstenedione in
microemulsions and their components. European journal of pharmaceutics and
biopharmaceutics, 2004. 58(1): p. 137-143.

26.

Gao, X., et al., Preparation and properties of a chitosan-based carrier of corneal
endothelial cells. Journal of Materials Science: Materials in Medicine, 2008.
19(12): p. 3611-3619.

27.

Lam, M.T., et al., The effect of continuous wavy micropatterns on silicone
substrates on the alignment of skeletal muscle myoblasts and myotubes.
Biomaterials, 2006. 27(24): p. 4340-4347.

28.

Lam, M.T., W.C. Clem, and S. Takayama, Reversible on-demand cell alignment
using reconfigurable microtopography. Biomaterials, 2008. 29(11): p. 1705-1712.

29.

Kumar, P., A. Pandit, and D.I. Zeugolis, Progress in Corneal Stromal Repair:
From Tissue Grafts and Biomaterials to Modular Supramolecular Tissue‐Like
Assemblies. Advanced Materials, 2016. 28(27): p. 5381-5399.

30.

Kawakita, T., et al., Preservation and expansion of the primate keratocyte
phenotype by downregulating TGF-β signaling in a low-calcium, serum-free
medium. Investigative ophthalmology & visual science, 2006. 47(5): p. 19181927.
174

31.

Doughty, M.J. and M.L. Zaman, Human corneal thickness and its impact on
intraocular pressure measures: a review and meta-analysis approach. Survey of
ophthalmology, 2000. 44(5): p. 367-408.

32.

Baker, H.R., E.F. Merschrod S, and K.M. Poduska, Electrochemically controlled
growth and positioning of suspended collagen membranes. Langmuir, 2008. 24(7):
p. 2970-2972.

33.

Kishore, V., et al., Tenogenic differentiation of human MSCs induced by the
topography of electrochemically aligned collagen threads. Biomaterials, 2012.
33(7): p. 2137-2144.

34.

Uquillas, J.A., V. Kishore, and O. Akkus, Effects of phosphate-buffered saline
concentration and incubation time on the mechanical and structural properties of
electrochemically aligned collagen threads. Biomedical Materials, 2011. 6(3): p.
035008.

35.

Meek, K.M. and C. Boote, The organization of collagen in the corneal stroma.
Experimental eye research, 2004. 78(3): p. 503-512.

36.

Gendron, R., et al., Controlled cell proliferation on an electrochemically
engineered collagen scaffold. Macromolecular bioscience, 2012. 12(3): p. 360366.

37.

Webster, V.A., et al., Effect of actuating cell source on locomotion of organic
living machines with electrocompacted collagen skeleton. Bioinspiration &
biomimetics, 2016. 11(3): p. 036012.

38.

Lawrence, B.D., et al., Human corneal limbal epithelial cell response to varying
silk film geometric topography in vitro. Acta biomaterialia, 2012. 8(10): p. 37323743.

39.

Liu, Y., L. Ren, and Y. Wang, A novel collagen film with micro-rough surface
structure for corneal epithelial repair fabricated by freeze drying technique.
Applied Surface Science, 2014. 301: p. 396-400.

40.

Gil, E.S., et al., Response of human corneal fibroblasts on silk film surface
patterns. Macromolecular bioscience, 2010. 10(6): p. 664-673.

41.

Nara, S., et al., Strategies for faster detachment of corneal cell sheet using
micropatterned thermoresponsive matrices. Journal of Materials Chemistry B,
2015. 3(20): p. 4155-4169.

42.

Du, Y., et al., Secretion and organization of a cornea-like tissue in vitro by stem
cells from human corneal stroma. Investigative ophthalmology & visual science,
175

2007. 48(11): p. 5038-5045.
43.

Wang, T.-J., et al., Novel chitosan-polycaprolactone blends as potential scaffold
and carrier for corneal endothelial transplantation. Molecular vision, 2012. 18:
p. 255.

44.

Funderburgh, J.L., M.M. Mann, and M.L. Funderburgh, Keratocyte phenotype
mediates proteoglycan structure a role for fibroblasts in corneal fibrosis. Journal
of Biological Chemistry, 2003. 278(46): p. 45629-45637.

45.

Liu, Y., et al., Properties of porcine and recombinant human collagen matrices for
optically clear tissue engineering applications. Biomacromolecules, 2006. 7(6):
p. 1819-1828.

46.

McCarey, B.E. and F.H. Schmidt, Modeling glucose distribution in the cornea.
Current eye research, 1990. 9(11): p. 1025-1039.

176

Chapter 6
Biological characterizations of corneal stromal
model

177

Contents
6.1 Introduction
6.2 Experimental section
6.2.1 Reagents and materials
6.2.2 3D distribution analysis of hCSCs
6.2.3 Live/dead analysis of hCSCs
6.2.4 hCSCs proliferation analysis
6.2.5 Immunocytochemistry
6.2.6 Real-Time Quantitative PCR (qPCR)
6.2.7 Statistical analysis
6.3 Results and Discussion
6.3.1 3D distribution analysis of hCSCs
6.3.2 hCSCs survival and proliferation in growth media and CSMs.
6.3.3 hCSCs proliferation analysis
6.3.4 Effect of CSMs on hCSCs phenotype
6.4 Conclusion
6.5 References

6.1 Introduction
The native corneal stroma consists of hundreds of orthogonally arranged collagen
lamellae and is populated with corneal keratocytes [1]. Normally, corneal keratocytes are
responsible for secreting transparent collagen matrix and in a stable and quiescent state
throughout the whole life without undergoing obvious apoptotic and mitotic processes
[2]. When responding to external stimuli (e.g. surgery, trauma, infection), unlike corneal
epithelium which relies on a self-renew cell cycle from limbal stem cells, corneal stroma
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scarring is processed by corneal fibroblasts/myofibroblasts which are derived from
keratocytes [3] (Figure 6.1).

Figure 6.1. Corneal keratocytes differentiation in wound healing.
Corneal keratocytes are dendritic cells and important for maintaining collagen lamellar
organization and regulating corneal stromal ECM [1]. Sufficient numbers of corneal
stromal cells with a keratocyte phenotype is an essential prerequisite for in vitro
regeneration of corneal stroma [4]. Recently, more attention has been given to
bioengineering a 3D environments to preserve keratocyte phenotype [5, 6]. However,
there have been no reported studies on manipulating the phenotype of corneal stromal
cells in mechanically strong and biomimetic collagen-based corneal stromal models.

Upon wound healing, corneal keratocytes migrate and differentiate into corneal
fibroblasts which are highly proliferative. In the healing phase of incisional corneal
wounds, myofibroblasts are usually observed and remain proliferative and migratory [7].
During the whole process, the characteristics of keratocytes are gradually lost; such as
their ability to secrete transparent ECM [8]. It has long been reported that the in vitro
cultured fibroblasts are capable of regaining keratocyte characteristics with increased
secretion of collagen, upregulated expression of keratocytes markers, and markedly
downregulated fibroblasts markers, by adjusting the recipe of culture media [9]. The
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presence of serum, for instance, can lead to apparent differentiation into fibroblasts while
serum-free media with various supplements can induce a keratocyte trend [10]. More
recently, applying suitable external culture environment, including 2D and 3D scaffolds,
has been extensively explored to manipulate the cell phenotype of corneal stromal cells
[5, 6, 11, 12]. Compared to TCP, the presence of collagen fibrils (collagen coating[11]
and collagen substrate[6]) can significantly upregulate the expression of keratocytes
marker and downregulate that of fibroblast marker. 3D collagen environment (collagen
sponge[5] and electro-spun frame-based scaffolds[4]) can induce the increase of ALDH3
expression and the down-regulation of a-SMA compared with 2D collagen.

In this chapter, the 3D distribution and morphology of hCSCs in CSMs were firstly
studied using F-actin/DAPI staining and the cell viability and proliferation were
monitored in SFM for up to 2 weeks. Moreover, the cells were immunostained and the
effects of aligned collagen fibrils and 3D biomimetic environment on the phenotype of
hCSCs were investigated by evaluating the gene expressions of corneal keratocyte and
fibroblast markers using qPCR.

6.2 Experimental section
6.2.1 Reagents and materials
DMEM/F-12 (Dulbecco's Modified Eagle Medium/Nutrient Mixture F-12), HEPES (4(2-hydroxyethyl)-1-piperazineethanesulfonic acid) with high glucose (Life Technologies,
Mulgrave, Australia), supplemented with 10% fetal bovine serum, Calcein
AM/propidium iodide (PI) (Life Technologies), DMEM/F 12 no red(Life Technologies,
21041025), TrypLE™ Select Enzyme (Life Technologies, 12563029), Basic fibroblast
growth factor (bFGF)(Life Technologies, 13256029), Albumin bovine serum (Sigma,
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A3059), Fetal Bovine Serum(Interpath, SFBSN2), Presto Blue™ (Life Technologies,
Mulgrave, Australia), Triton X-100 (Sigma-Aldrich, Australia), fluorescence conjugated
antibodies KI67 (mouse, 1:200; Invitrogen), 6-diamidino-2-phenylindole (DAPI, 10
μg/mL) (ThermoFisher Scientific, Waltham, MA, USA), Alexa-488 phalloidin
(ThermoFisher Scientific, Waltham, MA, USA), Insulin-Transferrin-Selenium-X
Supplement (100X)(Life Technologies, 51500056), Aurum™ Total RNA 96 Kit (Biorad, 7326800), iScript RT Supermix, 100 rxns (Bio-rad, 1708841), SYBR® Select Master
Mix(Life Technologies, 4472897) were procured.
Table 6.1. Primers for qPCR
Primer name

Abbreviation

Primer sequence

Thy-1

THY-1

Forward:
ATGAACCTGGCCATCAGCATCGC
Reverse:
CGAGGTGTTCTGAGCCAGCAGGC

Aldehyde dehydrogenase 3

ALDH3

Forward:
ACTCAGCAGGACGAGCTCTAC
Reverse: GGGTCACAGAGGATGTAGTC

Alpha-smooth muscle actin

α-SMA

Forward: CCGTGATCTCCTTCTGCATT
Reverse: CTGTTCCAGCCATCCTTCAT

Eukaryotic 18S

18s

Forward:
CGGCTACCACATCCAAGGAA
Reverse: GCTGGAATTACCGCGGCT

6.2.2 3D distribution analysis of hCSCs
The 3D distribution of CSMs was analysed using optical microscopy and confocal
microscopy. For F-actin staining, samples were permeabilised with 0.1% Triton X-100
for 10 min after fixation and then stained with Alexa 488-Phalloidin (ThermoFisher
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Scientific, Waltham, MA, USA) in1% BSA for 40 min at RT in the dark and the nuclei
were visualized using DAPI before observation.

6.2.3 Live/dead analysis of hCSCs
Calcein AM and propidium iodide (PI) staining were used to assess live and dead hCSCs
respectively. Following 3 times (30s each) PBS washes, samples were stained with
calcein-AM (0.5mg/L) and PI (0.3mg/L) in PBS at 37 °C for 15 min. Live cells (green)
and dead cells (red) were then observed using a Leica TSC SP5 II Confocal Microscope.

6.2.4 hCSCs proliferation analysis
PrestoBlue (Invitrogen) assay was performed for cell proliferation analysis. CSMs were
incubated with 10% PrestoBlue reagent (v/v) in culture medium for 30 min at days 1, 3,
5, 7 and 14. The media were collected and transferred into 96-well plates to measure the
fluorescence of the test reagent using a FLUO star Omega Microplate Reader with the
excitation/emission wavelengths set at 560/590 nm for Presto-Blue.

6.2.5 Immunocytochemistry
Samples were washed with PBS and then fixed in 3.7% paraformaldehyde in PBS for 30
min at RT. Following 3 times (5mins each) PBS washes, samples were permeabilized
with 0.3% Triton X-100 in PBS supplemented with 5% (v/v) BSA at 4°C overnight and
washed again. Samples were then incubated with conjugated antibodies Ki67 (mouse;
Invitrogen, 334711) at 4°C overnight. After rinsing with 0.1% Triton X-100 in PBS,
samples were counterstained with DAPI, rinsed with PBS and observed using a Leica
TSC SP5 II Confocal Microscope.
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6.2.6 Real-Time Quantitative PCR (qPCR)
After 14 days culture, CSMs were rinsed with PBS to remove medium. Total RNA was
then isolated using AurumTM Total RNA Mini Kit on ice according to the manufacturer’s
protocol. hCSCs grown on EC membrane or TCPs were directly treated with lysis buffer,
while 3D CSMs constructs (multilayered/stacked hCSC-EC membranes) were deassembled into single/separate layers using tweezers prior to lysis. The quantity and
purity of RNA was assessed using a NanoDrop 2000c Spectrophotometer (Thermo
Scientific) and normalized accordingly to allow accurate comparison of gene expression
levelRNA was reverse transcribed to cDNA using iScript™ Reverse Transcription
Supermix (Bio-rad, 1708841) according to the manufacturer’s instructions followed by
assessment of cDNA. RT-qPCR was performed for 40 amplification cycles using
SYBRTM Select Master Mix for CFX (catalogue # 4472942) on a Bio-Rad CFX real
time instrument. hCSCs grown on TCP was used as a reference point for comparison. 18S
was used as the endogenous control for normalisation of expression levels. The data were
analyzed using the delta-delta Ct method. Primers for genes used were purchased from
Sigma Aldrich and primer sequences can be seen in Table 6.1.

6.2.7 Statistical analysis
Experimental data were analyzed statistically using ANOVA with Tukey post hoc test.
Homogeneity of variance tests were performed to confirm that the statistical assumptions
were met for ANOVA. P-values less than 0.05 were considered to be significant (*P≤0.05,
**P≤0.01, ***P ≤ 0.001). IBM SPSS statistics 25 was used for all analyses.
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6.3 Results and Discussion
6.3.1 3D distribution analysis of hCSCs

Figure 6.2. Optical image of CSM from the top view.

Figure 6.3. Orthogonally arranged layers of hCSCs within CSMs (scale bar: 300 μm). (A)
F-actin labelling of hCSCs in CSM showed orthogonal arrangement of cells in different
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layers (denoted by dashed arrows). (B) Alignment of hCSCs in the topmost to the
bottommost layer of a CSM.

The hCSCs within CSMs were principally arranged orthogonally from one layer to
another as evident by F-actin labelling of cells (Figure 6.2 and 6.3). The multilayer
structure of CSM was confirmed by SEM (Figure 5.16) and the 3D distribution of hCSCs
was confirmed by confocal microscopy, with cells observed on different planes from the
top to the bottom of a CSM, being orthogonally arranged from one layer to the next
(Figure 6.3). As the main component of human corneal stroma, collagen type I has been
widely investigated for corneal tissue engineering, either by direct mixing with corneal
stromal cells prior to gelation [13] or stromal cell-seeding onto collagen-coated
membranes that are stacked [14]. However, conventionally prepared type I collagen
hydrogel lacks an appropriately organized structure thereby necessitating mixing with
synthetic or other mechanically superior materials for structural integrity[15]. To the best
of our knowledge, robust and consistent biomimetic CSMs composed of pure collagen
and hCSCs have not previously been described. Nicolas et al successfully fabricated
orthogonal collagen scaffolds with a highly stroma-mimetic structure using an intense
magnetic field, but it required further covalent crosslinking for requisite mechanical
properties [16, 17]. In this study, the as-described EC membranes consisted of pure
collagen without addition of any other materials and toxic reagents. Moreover, the aligned
collagen fibrils of the membranes acted as a guidance for cell orientation and elongation,
eliminating the need for topographical or other modification.
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6.3.2 hCSCs survival and proliferation in growth media and CSMs.

Figure 6.4. Time course of live (Calcein AM) and dead (propidium iodide; PI) hCSCs
staining in CSMs. (Scale bar: 300 μm).

6.3.3 hCSCs proliferation analysis

Figure. 6.5. hCSCs expressed negligible levels of cell proliferation marker Ki67 at day
14 post-seeding; (Scale bar: 300 μm).
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Figure 6.6. PrestoBlue reading of hCSCs in CSMs at day 1, day 7 and day 14.

Calcein AM and PI staining showed high cell viability in CSMs from day 1 through to
day 14, with uniform distribution of hCSCs across EC layers and only a few cells were
undergoing apoptosis and necrosis as evident by confocal microscopy imaging (Figure
6.4). Consistent with the results shown in SFM (Figure 5.8), immunophenotyping at 14
days post-seeding demonstrated that hCSCs did not express the nuclear proliferation
marker Ki67 in the CSMs (Figure 6.5). Cell viability was corroborated by PrestoBlue
assay which showed stable metabolically active cell cultures from day 1 to day 14 (P>0.05)
(Figure 6.6). Low Ki67 expression with high Calcein in the CSMs suggest that the hCSCs
are in a static quiescent stage and is consistent with data from PrestoBlue assay suggesting
static quiescent cell cultures that did not expand over time.

187

6.3.4 Effect of CSMs on hCSCs phenotype

Figure 6.7. Comparative gene expression by RT-qPCR of hCSCs within 3D CSMs or on
2D EC and TCPs after 14 days culture. (A, B) Myofibroblast markers α-SMA and Thy1, respectively. (C) Keratocyte marker ALDH3 Gene expression is normalized to 18s and
expressed relative to TCP. *P≤0.05, **P≤0.01, ***P ≤ 0.001. n=3.
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Figure 6.8. RT-qPCR amplification cycle of hCSCs on TCP, 2D EC membrane and 3D
CSMs.
On corneal injury, the keratocytes are stimulated to become Thy-1 expressing fibroblasts
that proliferate and migrate to the wound site. Corneal keratocytes or corneal fibroblasts
can differentiate into myofibroblasts that express alpha smooth muscle actin (αSMA)[18].

RT-qPCR showed negligible expression of α-SMA and Thy-1 transcripts for 3D CSMand 2D EC-hCSCs, with levels being comparatively higher for cells cultured on TCPs
(P<0.001) (Figure 4A and B). By contrast, expression of keratocyte marker-ALDH3 was
upregulated for 3D CSM-hCSCs samples compared with 2D EC- hCSCs and TCP-hCSCs
(P<0.01) (Figure 4C).

Gene expression analysis by RT-qPCR indicated that 3D CSM-hCSCs were more
keratocyte-like compared to TCP-hCSCs, with upregulation of keratocyte-marker
ALDH3 and concomitant down-regulation of myofibroblast-markers α-SMA and Thy-1
transcript (Figure 7). 2D EC-hCSCs similarly expressed low to negligible levels of αSMA and Thy-1 transcripts, while both genes were upregulated for TCP-hCSCs (Figure
4A, B). Taken together, these results are consistent with the presence of collagen fibrils
favouring hCSCs with a keratocyte phenotype rather than activated fibroblasts [5], and is
supported by reports of up-regulation of keratocan and ALDH3 expression of bovine
corneal keratocytes cultured on collagen vitrigel with highly condensed collagen fibrils[6],
as well as suppression of α-SMA using aligned collagen fibrils compared to TCP and
non-aligned fibrils[11]. Interestingly, ALDH3 is a corneal crystallin which provides
protection against ultraviolet radiation, is important for maintaining cellular transparency,
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and is normally highly secreted by corneal keratocytes and to a lesser extent by corneal
fibroblast and myofibroblasts [19]. ALDH3 expression by hCSCs within 3D CSMs is
therefore consistent with constructs being transparent. In addition, higher ALDH
expression by 3D CSM-hCSCs compared with 2D EC-hCSCs suggests that a 3D
environment favours gene expression, and is consistent with a previous report of 3D
collagen sponge similarly supporting ALDH3 expression of corneal keratocytes
compared to 2D collagen and TCP [5].

In this study, we investigated the phenotype of hCSCs in biomimetic corneal stromal
model that consisted of orthogonally arranged aligned collagen fibrils without any
synthetic materials and on 2D portable collagen membranes. Consistent with previous
findings [5], the presence of aligned collagen fibrils (2D EC and 3D CSMs compared to
TCP) significantly down-regulated fibroblastic markers (α-SMA and Thy-1). 3D CSMs
showed a significant up-regulation of ALDH3 compared to 2D EC, with 5~6 fold increase
relative to TCP. This may have resulted from the orthogonally arranged collagen fibrils
of this stromal model. It has previously been reported that, compared to TCP, a stromal
model of PLDLA (poly (L,D lactic acid))-based electro-spun meshes was able to induce
appropriate 3 fold increase of ALDH3 expression after 14 days culture [4]. These
biomimetic CSMs with pure collagen fibrils, reported here, may be advantageous in terms
of partial recovery of the keratocyte phenotype.

6.4 Conclusion
In this chapter, the 3D biomimetic structure of CSMs was confirmed by optical
microscopy and confocal microscopy using F-actin/DAPI staining, with hCSCs
orthogonally arranged in different layers. The hCSCs within CSMs remained viable and
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non-proliferated in SFM up to 2 weeks, indicating a quiescent state akin to healthy
keratocytes of native human cornea. However, the cells also demonstrated a more
fibroblast-like morphology, with highly expressed a-SMA as evidenced by
immunofluorescence and qPCR. Interestingly, the expression of fibroblast markers (aSMA and Thy-1) can be affected by the presence of aligned collagen fibrils and 3D CSM,
with significant down-regulation observed after 14 days’ culture. Moreover, 3D CSM
was able to induce an increased expression of corneal keratocytes marker (ALDH3)
compared to 2D aligned collagen fibrils and TCP. Therefore, as-prepared CSMs hold
significant potential as a corneal stromal substitute that supports the growth of hCSCs and
preserves the native tissue cellular phenotypes required for both normal function as well
as repair.
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Conclusions and Future Work
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7.1 Summary and Conclusions
The work presented in this thesis demonstrated the utilization of electro-compacted
collagen on corneal bioengineering, including 2D EC membranes for corneal epithelial
regeneration and 3D-stacked structure for reconstructing biomimetic corneal stromal
model in vitro.A wide range of materials have been utilized as substrates for corneal
epithelial bioengineering and showed promising results both in vitro and in vivo [1].
Collagen, the main component of cornea, remains the best candidate, due to its excellent
biocompatibility [2], but its application is largely hindered by its weak mechanical
property which is normally enhanced via crosslinking or combining with synthetic
materials that are mechanically superior [3]. The rise of electro-compacted collagen
presents a bright opportunity for corneal epithelial regeneration for its enhanced
mechanical toughness [4]. Moreover, unlike NECC (conventional collagen gel) in which
fibrils appear in a random fashion, EC collagen is easily-handled and characterized by
aligned nano-structure, mimicking that of native human cornea [5]. The excellent
transmittance and glucose permeability observed suggested that the EC membrane was
eligible to serve as a corneal implant. While hCECs (human corneal epithelial cells)
remained highly viable and proliferated into confluence with a similar rate on both EC
and NECC, the cell attachment was significantly enhanced on EC with quick adhesion
and larger spreading area, suggesting ECC may be superior to NECC for corneal
epithelial bioengineering and regeneration.

Reconstructing biomimetic and functional corneal stroma is the core and main goal for
corneal bioengineering, which has been achieved in recent years and includes a wide
range of materials and techniques. Most of these instances, however, fabricated the
orthogonal structure via the combination of collagen and other materials (e.g. patterned
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silk membrane [6] and electro-spun poly (L,D lactic acid) (PLDLA) nanofibre meshes
[7]), and failed to achieve aligned collagen fibrils. The magnetic technique can fabricate
scaffolds with similar structure to human cornea stroma, but the resultant stromal model
is mechanically weak and requires covalent crosslinking [8, 9]. In Chapter 5, work was
presented on the first example of a robust biomimetic 3D corneal stromal model (CSM)
consisting of orthogonally arranged aligned collagen fibrils and hCSCs (human corneal
stromal cells). Unlike the previous reports of EC collagen which require further chemical
crosslinking, this study only treated collagen with PBS after compaction, which
eliminated the use of toxic chemicals and simplified the fabrication process. The
orientation of hCSCs was directed by the nano-topography of the electro-compacted
membrane, laying the foundation for the successful fabrication of a stroma-mimetic
structure. As-prepared CSMs demonstrated stable integrity, high transparency and
glucose-permeability in SFM (serum free media) up to 2 weeks. While the hCSCs of CSM
were in a quiescent state in which normal corneal keratocytes of native human corneal
are, the expression of corneal keratocytes and fibroblasts markers of hCSCs can be
regulated by 2D EC and 3D CSM to induce a keratocytes trend compared to those cultured
on TCP, suggesting that the CSM has a great potential for in vitro hCSCs culture, corneal
modeling and regeneration.

However, this study has several limitations due to time constraints. In terms of electrocompacting collagen membrane for corneal epithelial bioengineering (chapter 3), the
involvement of growth factors, which has been repeatedly reported as a perquisite for the
maintenance of primary corneal epithelial cells, should be considered [10, 11]. Moreover,
the relatively poor physical linking between collagen layers may impair the manipulation
of CSM in corneal transplantation (chapter 4); therefore the construction of CSM needs
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to be further developed to be more stable and robust through chemical crosslinking. As
mentioned in Chapter 1, favourable innervation is indispensable for fabricating functional
corneal replacement, as cornea is one of the most innervated tissues in human body.
Future research may need to focus more on the engagement and assessment of neural
regeneration. Finally, the in vivo performance of electro-compacted collagen and CSM,
which is an essential characterization for further clinic application, has not been
investigated. Further investigations on in vivo biodegradability, compatibility and
transparency may provide new insights to the development of bioengineered cornea.

7.2 Future Work.
Electro-compacted collagen has been extensively studied and demonstrated excellent in
vitro biocompatibility for various kinds of bio-applications [12-14].

The in vivo

performance, however, is rarely reported and needs to be explored in future work. Several
recent publications have provided insights into the co-compaction of collagen and other
materials [15, 16]. Chondroitin sulfate and hydroxyapatite, for instance, have been
directly mixed with collagen solution prior to compaction to achieve composite scaffolds.
This method, however, resulted in decreased mechanical toughness[16]. By adjusting the
isoelectric point of cellulose nanocrystals via changing the surface charges (i.e., the ratio
of carboxylic acid to amine moieties), collagen/ cellulose composite fibres can be
generated between the electrodes at where both the collagen and cellulose nanofibres are
aligned [15]. Exploring more native tissue-derived biomaterials for co-compaction and
the effect of introduced materials on the physiochemical and biological performances of
scaffolds will be of great interest in terms of bioengineering biomimetic and functional
human tissue.
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For corneal bioengineering, there is still a long way ahead to rebuild full-thickness and
functional biomimetic corneal tissue in vitro. 3D bioprinting, an emerging technique
which is able to construct complex 3D structures with a combination of cells, biomaterials
and biomolecules in defined locations, has garnered notable interest as an advanced
fabrication method for bioengineering cornea [17], offering unrivalled opportunities for
in vitro corneal modeling. Abigail et al extrusion-printed a corneal stroma equivalent
using sodium alginate/methacrylated collagen ink, with the viability of encapsulated
corneal keratocytes well maintained for up to 7 days after printing [18]. Nevertheless, the
printed scaffolds failed to achieve a biomimetic collagen structure. A multilayered nativelike 3D corneal structure comprising epithelium and stroma was successfully produced
using laser-assisted bioprinting, with collagen and laminin as bioink [19]. The printed
structure demonstrated good mechanical properties, excellent biocompatibility, and
interestingly, the collagen fibres showed some organization and alignment similar to that
of human corneal stroma.

While 3D bioprinting is able to fabricate bulky multilayered corneal structures [18], the
ongoing challenges for 3D printing cornea, however, resides in the following points.
Firstly, the reconstruction of the regions with complicated anatomical structure, such as
the limbal zone, bowman’s layer, stroma, is by far not achieved and requires the
development of printing techniques with incredibly high resolution and ideally, the ability
to control the alignment of collagen fibrils. Secondly, the current protocols for epithelial,
stromal, endothelial cells differ a lot from each other. The co-culture technique for
multiple corneal cell types thus needs to be well developed. Moreover, as the cornea is
one of the most innervated tissues in the human body, the regeneration of functional
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neurons through a printed cornea will also be worth considering. Last but not least, an
important interest will be the facilitation of the transplantation process and manipulation
of cell differentiation and maturation by controlling the physiochemical properties of
printed cornea.

To facilitate the clinical application of bioengineered cornea, several desired
requirements should be considered. First and foremost, the mechanical properties need to
be optimized to sustain the suture and manipulation in corneal transplantation. The
electro-compacted membrane and CSM generated in this study demonstrated favourable
mechanical toughness but may require further optimization based on in vivo experiments.
Ideally, the perfect balance between biodegradation and corneal tissue regeneration rate
should be achieved to advance the restoration of corneal tissue; thus further investigation
addressing in vivo responses may provide new insights to the development of qualified
corneal replacement. In addition, stable and excellent transparency should be considered
to promote the long-term life quality of recipients. Last but not least, this research and
most published studies as reviewed used bovine collagen rather than expensive human
collagen. However, human sourced collagen is likely to produce an immunological
response that leads to tissue rejection. Therefore, use of sterilised human sourced collagen
would greatly assist with advancing the development of therapeutic collagen-based
bioengineered corneal substitutes.In spite of the challenges, there is little doubt that
corneal implants will be partly or completely engineered in vitro to provide alternatives
to current treatments thereby addressing the present shortfall in donor cornea. The rapid
advancement in biomaterials, cell biology and tissue engineering methods such as
bioprinting will facilitate the formation of durable biomimetic structures that are
customized to the individual needs of recipients; improving transplant durability and
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functionality, and ultimately the quality of life for the large numbers of patients
worldwide suffering from corneal blindness.
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